| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 OTOL1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 SCARA3 COL28A1 COL27A1 COL1A2 | 1.39e-69 | 46 | 47 | 29 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 OTOL1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 SCARA3 COL28A1 COL27A1 COL1A2 | 7.24e-48 | 188 | 47 | 29 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 OTOL1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 SCARA3 COL28A1 COL27A1 COL1A2 | 9.37e-28 | 891 | 47 | 29 | GO:0005198 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.32e-08 | 12 | 47 | 4 | GO:0048407 | |
| GeneOntologyMolecularFunction | heparin binding | 3.09e-07 | 192 | 47 | 7 | GO:0008201 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 2.88e-06 | 268 | 47 | 7 | GO:0005539 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 9.80e-06 | 323 | 47 | 7 | GO:1901681 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 3.44e-05 | 27 | 47 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 2.35e-04 | 51 | 47 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | growth factor binding | 4.92e-04 | 156 | 47 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 8.10e-04 | 18 | 47 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | collagen binding | 9.17e-04 | 81 | 47 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.05e-03 | 85 | 47 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 3.07e-03 | 35 | 47 | 2 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 3.07e-03 | 35 | 47 | 2 | GO:0071814 | |
| GeneOntologyMolecularFunction | integrin binding | 8.09e-03 | 175 | 47 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 8.73e-03 | 180 | 47 | 3 | GO:0004866 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 9.69e-03 | 187 | 47 | 3 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 1.18e-02 | 201 | 47 | 3 | GO:0061135 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.28e-02 | 73 | 47 | 2 | GO:0050840 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.30e-02 | 599 | 47 | 5 | GO:0050839 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL5A3 COL14A1 COL7A1 OTOL1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 SCARA3 COL28A1 COL27A1 COL1A2 | 7.79e-32 | 377 | 46 | 25 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL5A3 COL14A1 COL7A1 OTOL1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 SCARA3 COL28A1 COL27A1 COL1A2 | 8.33e-32 | 378 | 46 | 25 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL5A3 COL14A1 COL7A1 OTOL1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 SCARA3 COL28A1 COL27A1 COL1A2 | 8.91e-32 | 379 | 46 | 25 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | COL2A1 COL5A1 COL5A3 COL14A1 COL11A1 COL11A2 COL28A1 COL27A1 COL1A2 | 7.58e-14 | 76 | 46 | 9 | GO:0030199 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.06e-08 | 12 | 46 | 4 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 6.47e-08 | 18 | 46 | 4 | GO:0038065 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | COL2A1 CKAP5 COL5A1 COL5A3 COL14A1 COL11A1 COL11A2 COL28A1 COL27A1 COL1A2 | 3.92e-05 | 957 | 46 | 10 | GO:0097435 |
| GeneOntologyBiologicalProcess | skeletal system development | COL2A1 COL9A2 COL11A1 COL11A2 COL13A1 COL19A1 COL27A1 COL1A2 | 5.73e-05 | 615 | 46 | 8 | GO:0001501 |
| GeneOntologyBiologicalProcess | tendon development | 1.01e-04 | 7 | 46 | 2 | GO:0035989 | |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 2.16e-04 | 10 | 46 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | chondrocyte differentiation | 2.19e-04 | 133 | 46 | 4 | GO:0002062 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 3.68e-04 | 277 | 46 | 5 | GO:0048705 | |
| GeneOntologyBiologicalProcess | carbohydrate mediated signaling | 3.74e-04 | 13 | 46 | 2 | GO:0009756 | |
| GeneOntologyBiologicalProcess | cellular response to amino acid stimulus | 4.52e-04 | 161 | 46 | 4 | GO:0071230 | |
| GeneOntologyBiologicalProcess | negative regulation of cell size | 5.02e-04 | 15 | 46 | 2 | GO:0045792 | |
| GeneOntologyBiologicalProcess | cellular response to acid chemical | 6.46e-04 | 177 | 46 | 4 | GO:0071229 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 7.29e-04 | 79 | 46 | 3 | GO:0060350 | |
| GeneOntologyBiologicalProcess | connective tissue development | 9.68e-04 | 343 | 46 | 5 | GO:0061448 | |
| GeneOntologyBiologicalProcess | sensory perception of sound | 9.81e-04 | 198 | 46 | 4 | GO:0007605 | |
| GeneOntologyBiologicalProcess | response to amino acid | 1.06e-03 | 202 | 46 | 4 | GO:0043200 | |
| GeneOntologyBiologicalProcess | circulatory system development | COL2A1 COL4A1 COL4A3 COL5A1 COL14A1 COL11A1 ADRA2B COL15A1 COL27A1 COL1A2 | 1.08e-03 | 1442 | 46 | 10 | GO:0072359 |
| GeneOntologyBiologicalProcess | cartilage condensation | 1.19e-03 | 23 | 46 | 2 | GO:0001502 | |
| GeneOntologyBiologicalProcess | notochord development | 1.30e-03 | 24 | 46 | 2 | GO:0030903 | |
| GeneOntologyCellularComponent | collagen trimer | COL2A1 MSR1 COL4A1 C1QTNF9B COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COLEC12 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 OTOL1 COL6A5 COL9A2 C1QTNF2 COL11A1 COL22A1 COL11A2 GLDN COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 SCARA3 COL28A1 COL27A1 C1QTNF9 COL1A2 | 5.17e-76 | 88 | 48 | 35 | GO:0005581 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COLEC12 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 OTOL1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 SCARA3 COL28A1 COL27A1 COL1A2 | 2.80e-36 | 530 | 48 | 30 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COLEC12 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 OTOL1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 ZAN COL6A6 COL21A1 SCARA3 COL28A1 COL27A1 COL1A2 | 3.19e-35 | 656 | 48 | 31 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COLEC12 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 OTOL1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 ZAN COL6A6 COL21A1 SCARA3 COL28A1 COL27A1 COL1A2 | 3.51e-35 | 658 | 48 | 31 | GO:0030312 |
| GeneOntologyCellularComponent | complex of collagen trimers | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A3 COL7A1 COL11A1 COL11A2 COL28A1 COL27A1 COL1A2 | 1.60e-33 | 21 | 48 | 14 | GO:0098644 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL21A1 COL28A1 COL27A1 COL1A2 | 9.44e-33 | 332 | 48 | 25 | GO:0005788 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 2.05e-19 | 12 | 48 | 8 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 2.05e-19 | 12 | 48 | 8 | GO:0098643 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 2.96e-15 | 8 | 48 | 6 | GO:0098651 | |
| GeneOntologyCellularComponent | basement membrane | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL7A1 COL15A1 COL28A1 | 3.18e-15 | 122 | 48 | 11 | GO:0005604 |
| GeneOntologyCellularComponent | collagen type IV trimer | 3.08e-13 | 6 | 48 | 5 | GO:0005587 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 2.87e-12 | 8 | 48 | 5 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 2.87e-12 | 8 | 48 | 5 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 1.22e-10 | 5 | 48 | 4 | GO:0005592 | |
| GeneOntologyCellularComponent | collagen type V trimer | 4.54e-08 | 4 | 48 | 3 | GO:0005588 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 2.26e-07 | 6 | 48 | 3 | GO:0005593 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 CKAP5 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A3 COL11A1 COL11A2 COL28A1 COL27A1 COL1A2 | 2.62e-07 | 1187 | 48 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | anchoring collagen complex | 1.55e-05 | 3 | 48 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | collagen type IX trimer | 3.09e-05 | 4 | 48 | 2 | GO:0005594 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL2A1 CKAP5 COL5A1 COL5A3 COL11A1 COL11A2 COL28A1 COL27A1 COL1A2 | 1.28e-03 | 1179 | 48 | 9 | GO:0099512 |
| HumanPheno | Lenticonus | 5.39e-08 | 10 | 22 | 4 | HP:0001142 | |
| HumanPheno | Glomerular basement membrane lamellation | 6.99e-08 | 3 | 22 | 3 | HP:0030034 | |
| HumanPheno | Anterior lenticonus | 6.99e-08 | 3 | 22 | 3 | HP:0011501 | |
| HumanPheno | Myopia | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL9A2 COL11A1 COL11A2 COL1A2 | 6.09e-07 | 447 | 22 | 11 | HP:0000545 |
| HumanPheno | Degenerative vitreoretinopathy | 6.96e-07 | 5 | 22 | 3 | HP:0007964 | |
| HumanPheno | Abnormality of lens shape | 7.68e-07 | 18 | 22 | 4 | HP:0011526 | |
| HumanPheno | Glomerular deposits | 1.21e-06 | 20 | 22 | 4 | HP:0030949 | |
| HumanPheno | Vitreoretinopathy | 1.81e-06 | 22 | 22 | 4 | HP:0007773 | |
| HumanPheno | Dumbbell-shaped long bone | 2.42e-06 | 7 | 22 | 3 | HP:0000947 | |
| HumanPheno | Esophageal neoplasm | 5.78e-06 | 29 | 22 | 4 | HP:0100751 | |
| HumanPheno | Osteoarthritis | 6.45e-06 | 65 | 22 | 5 | HP:0002758 | |
| HumanPheno | Abnormality of upper limb joint | COL2A1 COL5A1 COL6A2 COL7A1 COL9A2 COL11A1 COL11A2 GLDN COL13A1 SPEN COL27A1 COL1A2 | 7.70e-06 | 705 | 22 | 12 | HP:0009810 |
| HumanPheno | Abnormality of refraction | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL9A2 COL11A1 COL11A2 SPEN COL1A2 | 8.18e-06 | 709 | 22 | 12 | HP:0000539 |
| HumanPheno | Bell-shaped thorax | 9.84e-06 | 33 | 22 | 4 | HP:0001591 | |
| HumanPheno | Pierre-Robin sequence | 1.11e-05 | 34 | 22 | 4 | HP:0000201 | |
| HumanPheno | Thickened glomerular basement membrane | 1.50e-05 | 12 | 22 | 3 | HP:0004722 | |
| HumanPheno | Atrophic scars | 1.57e-05 | 37 | 22 | 4 | HP:0001075 | |
| HumanPheno | Neoplasm of head and neck | 1.75e-05 | 38 | 22 | 4 | HP:0012288 | |
| HumanPheno | Tracheobronchial leiomyomatosis | 1.78e-05 | 2 | 22 | 2 | HP:0006524 | |
| HumanPheno | Dyspepsia | 1.78e-05 | 2 | 22 | 2 | HP:0410281 | |
| HumanPheno | Diffuse leiomyomatosis | 1.78e-05 | 2 | 22 | 2 | HP:0006756 | |
| HumanPheno | Abnormal glomerular basement membrane morphology | 1.95e-05 | 13 | 22 | 3 | HP:0033282 | |
| HumanPheno | Glomerular subepithelial deposits | 2.47e-05 | 14 | 22 | 3 | HP:0033603 | |
| HumanPheno | Abnormal hip bone morphology | COL2A1 COL5A1 COL6A2 COL9A2 COL11A1 COL11A2 COL13A1 SPEN STAG2 COL27A1 COL1A2 | 2.61e-05 | 653 | 22 | 11 | HP:0003272 |
| HumanPheno | Knee osteoarthritis | 3.08e-05 | 15 | 22 | 3 | HP:0005086 | |
| HumanPheno | Hypoplastic ischia | 3.78e-05 | 16 | 22 | 3 | HP:0003175 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 3.95e-05 | 94 | 22 | 5 | HP:0006500 | |
| HumanPheno | Enlarged thorax | 3.95e-05 | 94 | 22 | 5 | HP:0100625 | |
| HumanPheno | Knee pain | 4.57e-05 | 17 | 22 | 3 | HP:0030839 | |
| HumanPheno | Abnormal lens morphology | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL7A1 COL9A2 COL11A1 COL11A2 SPEN | 4.66e-05 | 837 | 22 | 12 | HP:0000517 |
| HumanPheno | Abnormal vitreous humor morphology | 4.87e-05 | 49 | 22 | 4 | HP:0004327 | |
| HumanPheno | Vulvar neoplasm | 5.33e-05 | 3 | 22 | 2 | HP:0030416 | |
| HumanPheno | Precordial pain | 5.33e-05 | 3 | 22 | 2 | HP:0032141 | |
| HumanPheno | Thin glomerular basement membrane | 5.33e-05 | 3 | 22 | 2 | HP:0012577 | |
| HumanPheno | Dermal atrophy | 7.38e-05 | 107 | 22 | 5 | HP:0004334 | |
| HumanPheno | Abnormal tibia morphology | 7.38e-05 | 107 | 22 | 5 | HP:0002992 | |
| HumanPheno | Abnormal pelvic girdle bone morphology | COL2A1 COL5A1 COL6A2 COL9A2 COL11A1 COL11A2 COL13A1 SPEN STAG2 COL27A1 COL1A2 | 7.57e-05 | 730 | 22 | 11 | HP:0002644 |
| HumanPheno | Hip dislocation | 7.89e-05 | 263 | 22 | 7 | HP:0002827 | |
| HumanPheno | Limb pain | 8.87e-05 | 57 | 22 | 4 | HP:0009763 | |
| HumanPheno | Abnormal hip joint morphology | COL2A1 COL5A1 COL6A2 COL9A2 COL13A1 SPEN STAG2 COL27A1 COL1A2 | 1.04e-04 | 490 | 22 | 9 | HP:0001384 |
| HumanPheno | short, dumbbell appearance of long bones | 1.06e-04 | 4 | 22 | 2 | HP:0005061 | |
| HumanPheno | Dumbbell-shaped femur | 1.06e-04 | 4 | 22 | 2 | HP:0006375 | |
| HumanPheno | Pretibial blistering | 1.06e-04 | 4 | 22 | 2 | HP:0012221 | |
| HumanPheno | Abnormality of the distal femoral epiphysis | 1.06e-04 | 4 | 22 | 2 | HP:0010590 | |
| HumanPheno | Retinal detachment | 1.18e-04 | 118 | 22 | 5 | HP:0000541 | |
| HumanPheno | Abnormality of the elbow | 1.23e-04 | 282 | 22 | 7 | HP:0009811 | |
| HumanPheno | Abnormal synovial membrane morphology | COL2A1 COL5A1 COL6A2 COL9A2 COL13A1 SPEN STAG2 COL27A1 COL1A2 | 1.27e-04 | 503 | 22 | 9 | HP:0005262 |
| HumanPheno | Small epiphyses | 1.33e-04 | 24 | 22 | 3 | HP:0010585 | |
| HumanPheno | Platyspondyly | 1.49e-04 | 124 | 22 | 5 | HP:0000926 | |
| HumanPheno | Irregular epiphyses | 1.51e-04 | 25 | 22 | 3 | HP:0010582 | |
| HumanPheno | Abnormal femoral neck/head morphology | 1.54e-04 | 201 | 22 | 6 | HP:0003366 | |
| HumanPheno | Gastroesophageal reflux | 1.58e-04 | 517 | 22 | 9 | HP:0002020 | |
| HumanPheno | Abnormality of tibial epiphyses | 1.77e-04 | 5 | 22 | 2 | HP:0006508 | |
| HumanPheno | Coxa vara | 1.77e-04 | 68 | 22 | 4 | HP:0002812 | |
| HumanPheno | Small joint hypermobilty | 1.88e-04 | 69 | 22 | 4 | HP:0430046 | |
| HumanPheno | Abnormal ischium morphology | 1.91e-04 | 27 | 22 | 3 | HP:0003174 | |
| HumanPheno | Abnormal corneal epithelium morphology | 2.00e-04 | 132 | 22 | 5 | HP:0011495 | |
| HumanPheno | Tube feeding | 2.23e-04 | 215 | 22 | 6 | HP:0033454 | |
| HumanPheno | Cataract | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL7A1 COL9A2 COL11A1 COL11A2 SPEN | 2.29e-04 | 822 | 22 | 11 | HP:0000518 |
| HumanPheno | Cupped ribs | 2.38e-04 | 29 | 22 | 3 | HP:0000887 | |
| HumanPheno | Epiphyseal dysplasia | 2.38e-04 | 29 | 22 | 3 | HP:0002656 | |
| HumanPheno | Atypical scarring of skin | 2.46e-04 | 74 | 22 | 4 | HP:0000987 | |
| HumanPheno | Abnormal limb epiphysis morphology | 2.46e-04 | 138 | 22 | 5 | HP:0006505 | |
| HumanPheno | Lower extremity joint dislocation | 2.61e-04 | 318 | 22 | 7 | HP:0030311 | |
| HumanPheno | Short scapulae | 2.63e-04 | 30 | 22 | 3 | HP:0000906 | |
| HumanPheno | Hypoplastic scapulae | 2.63e-04 | 30 | 22 | 3 | HP:0000882 | |
| HumanPheno | Micrognathia | COL2A1 COL5A1 COL6A2 COL9A2 COL11A1 COL11A2 GLDN COL13A1 SPEN STAG2 COL1A2 | 2.88e-04 | 843 | 22 | 11 | HP:0000347 |
| HumanPheno | Short femur | 2.91e-04 | 31 | 22 | 3 | HP:0003097 | |
| HumanPheno | Aplasia/Hypoplasia of the scapulae | 2.91e-04 | 31 | 22 | 3 | HP:0006713 | |
| HumanPheno | Joint subluxation | 2.91e-04 | 31 | 22 | 3 | HP:0032153 | |
| HumanPheno | Aplasia/Hypoplasia of the mandible | COL2A1 COL5A1 COL6A2 COL9A2 COL11A1 COL11A2 GLDN COL13A1 SPEN STAG2 COL1A2 | 2.94e-04 | 845 | 22 | 11 | HP:0009118 |
| HumanPheno | Glossoptosis | 3.20e-04 | 32 | 22 | 3 | HP:0000162 | |
| HumanPheno | Esophageal stenosis | 3.51e-04 | 33 | 22 | 3 | HP:0010450 | |
| HumanPheno | Abnormality of lower limb joint | COL2A1 COL5A1 COL6A2 COL7A1 COL9A2 COL11A1 COL11A2 COL13A1 SPEN STAG2 COL27A1 COL1A2 | 3.66e-04 | 1027 | 22 | 12 | HP:0100491 |
| HumanPheno | Esophageal ulceration | 3.69e-04 | 7 | 22 | 2 | HP:0004791 | |
| HumanPheno | Lens luxation | 3.69e-04 | 7 | 22 | 2 | HP:0012019 | |
| HumanPheno | Abnormal forearm morphology | 3.96e-04 | 239 | 22 | 6 | HP:0002973 | |
| HumanPheno | Malar flattening | 4.05e-04 | 240 | 22 | 6 | HP:0000272 | |
| HumanPheno | Abnormal femoral epiphysis morphology | 4.39e-04 | 86 | 22 | 4 | HP:0006499 | |
| HumanPheno | Abnormal femoral neck morphology | 4.90e-04 | 160 | 22 | 5 | HP:0003367 | |
| HumanPheno | Arterial rupture | 4.91e-04 | 8 | 22 | 2 | HP:0025019 | |
| HumanPheno | Anti-smooth muscle antibody positivity | 4.91e-04 | 8 | 22 | 2 | HP:0003262 | |
| HumanPheno | Fragile skin | 4.94e-04 | 37 | 22 | 3 | HP:0001030 | |
| HumanPheno | Abnormal malar bone morphology | 4.94e-04 | 249 | 22 | 6 | HP:0012369 | |
| HumanPheno | Abnormal stomach morphology | COL2A1 MSR1 COL4A5 COL4A6 COL5A1 COL14A1 COL7A1 COL13A1 SPEN STAG2 | 4.96e-04 | 742 | 22 | 10 | HP:0002577 |
| HumanPheno | Abnormal zygomatic arch morphology | 5.05e-04 | 250 | 22 | 6 | HP:0005557 | |
| HumanPheno | Abnormal zygomatic bone morphology | 5.05e-04 | 250 | 22 | 6 | HP:0010668 | |
| HumanPheno | Coxa valga | 5.68e-04 | 92 | 22 | 4 | HP:0002673 | |
| HumanPheno | Flexion contracture of finger | 5.85e-04 | 257 | 22 | 6 | HP:0012785 | |
| HumanPheno | Bifid uvula | 5.97e-04 | 167 | 22 | 5 | HP:0000193 | |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | COL2A1 COL5A1 COL6A2 COL9A2 COL11A1 COL11A2 GLDN COL13A1 SPEN STAG2 COL1A2 | 6.04e-04 | 915 | 22 | 11 | HP:0009116 |
| HumanPheno | Finger joint contracture | 6.10e-04 | 259 | 22 | 6 | HP:0034681 | |
| HumanPheno | High myopia | 6.17e-04 | 94 | 22 | 4 | HP:0011003 | |
| HumanPheno | Arthralgia of the hip | 6.29e-04 | 9 | 22 | 2 | HP:0003365 | |
| HumanPheno | Tibial bowing | 6.70e-04 | 41 | 22 | 3 | HP:0002982 | |
| HumanPheno | Lower limb pain | 6.70e-04 | 41 | 22 | 3 | HP:0012514 | |
| HumanPheno | Vertebral clefting | 6.70e-04 | 41 | 22 | 3 | HP:0008428 | |
| HumanPheno | Abnormality of the inner ear | COL2A1 COL4A3 COL4A5 COL4A6 COL9A2 COL11A1 COL11A2 COL13A1 SPEN STAG2 COL27A1 COL1A2 | 7.25e-04 | 1102 | 22 | 12 | HP:0000359 |
| HumanPheno | Lumbar hyperlordosis | 7.50e-04 | 99 | 22 | 4 | HP:0002938 | |
| HumanPheno | Lens dislocation | 7.72e-04 | 43 | 22 | 3 | HP:0000665 | |
| MousePheno | hematuria | 1.56e-07 | 19 | 37 | 4 | MP:0005161 | |
| MousePheno | podocyte foot process effacement | 2.87e-06 | 38 | 37 | 4 | MP:0008140 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 5.23e-06 | 44 | 37 | 4 | MP:0011348 | |
| MousePheno | abnormal podocyte foot process morphology | 1.29e-05 | 55 | 37 | 4 | MP:0008059 | |
| MousePheno | albuminuria | 2.21e-05 | 63 | 37 | 4 | MP:0002871 | |
| MousePheno | abnormal podocyte morphology | 3.36e-05 | 70 | 37 | 4 | MP:0005326 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 3.36e-05 | 70 | 37 | 4 | MP:0011497 | |
| MousePheno | abnormal limb joint morphology | 3.77e-05 | 25 | 37 | 3 | MP:0030805 | |
| MousePheno | increased renal glomerulus basement membrane thickness | 4.78e-05 | 27 | 37 | 3 | MP:0011409 | |
| MousePheno | abnormal chondrocyte morphology | 6.57e-05 | 83 | 37 | 4 | MP:0000166 | |
| MousePheno | abnormal glomerular mesangium morphology | 6.57e-05 | 83 | 37 | 4 | MP:0011339 | |
| MousePheno | renal tubule atrophy | 6.60e-05 | 30 | 37 | 3 | MP:0011346 | |
| MousePheno | renal glomerular synechia | 6.78e-05 | 5 | 37 | 2 | MP:0011483 | |
| MousePheno | decreased tendon stiffness | 6.78e-05 | 5 | 37 | 2 | MP:0003098 | |
| MousePheno | abnormal renal glomerulus basement membrane thickness | 7.29e-05 | 31 | 37 | 3 | MP:0011349 | |
| MousePheno | pale kidney | 8.82e-05 | 33 | 37 | 3 | MP:0004969 | |
| MousePheno | renal cast | 9.65e-05 | 34 | 37 | 3 | MP:0011402 | |
| MousePheno | abnormal tendon physiology | 1.02e-04 | 6 | 37 | 2 | MP:0030802 | |
| MousePheno | micromelia | 1.02e-04 | 6 | 37 | 2 | MP:0008736 | |
| MousePheno | abnormal tendon stiffness | 1.02e-04 | 6 | 37 | 2 | MP:0003097 | |
| MousePheno | abnormal capillary morphology | 1.02e-04 | 93 | 37 | 4 | MP:0003658 | |
| MousePheno | sensorineural hearing loss | 1.25e-04 | 37 | 37 | 3 | MP:0004740 | |
| MousePheno | abnormal muscle physiology | COL4A1 C1QTNF9B COL5A3 COL14A1 ADRA2B COL13A1 COL15A1 COL19A1 C1QTNF9 COL1A2 | 1.33e-04 | 954 | 37 | 10 | MP:0002106 |
| MousePheno | increased large unstained cell number | 1.35e-04 | 38 | 37 | 3 | MP:0012362 | |
| MousePheno | sensorineural hearing impairment | 1.35e-04 | 38 | 37 | 3 | MP:0006329 | |
| MousePheno | retrognathia | 1.42e-04 | 7 | 37 | 2 | MP:0004282 | |
| MousePheno | abnormal basement membrane morphology | 1.58e-04 | 40 | 37 | 3 | MP:0004272 | |
| MousePheno | abnormal renal glomerular capsule morphology | 1.76e-04 | 107 | 37 | 4 | MP:0002828 | |
| MousePheno | prominent forehead | 1.89e-04 | 8 | 37 | 2 | MP:0030049 | |
| MousePheno | abnormal hyaline cartilage morphology | 2.40e-04 | 46 | 37 | 3 | MP:0006429 | |
| MousePheno | expanded mesangial matrix | 2.40e-04 | 46 | 37 | 3 | MP:0011353 | |
| MousePheno | abnormal knee joint morphology | 2.43e-04 | 9 | 37 | 2 | MP:0030837 | |
| MousePheno | dilated glomerular capillary | 2.43e-04 | 9 | 37 | 2 | MP:0011509 | |
| MousePheno | abnormal glomerular capillary morphology | 2.55e-04 | 47 | 37 | 3 | MP:0011320 | |
| MousePheno | abnormal kidney capillary morphology | 2.72e-04 | 48 | 37 | 3 | MP:0011310 | |
| MousePheno | abnormal synovial joint morphology | 3.11e-04 | 124 | 37 | 4 | MP:0030804 | |
| MousePheno | abnormal mesangial matrix morphology | 3.26e-04 | 51 | 37 | 3 | MP:0011338 | |
| MousePheno | kidney atrophy | 3.65e-04 | 53 | 37 | 3 | MP:0004970 | |
| MousePheno | abnormal large unstained cell number | 3.65e-04 | 53 | 37 | 3 | MP:0012360 | |
| MousePheno | myopathy | 3.86e-04 | 54 | 37 | 3 | MP:0000751 | |
| MousePheno | renal interstitial fibrosis | 3.86e-04 | 54 | 37 | 3 | MP:0003215 | |
| MousePheno | dilated capillary | 5.22e-04 | 13 | 37 | 2 | MP:0020326 | |
| MousePheno | increased percent body fat/body weight | 5.26e-04 | 60 | 37 | 3 | MP:0005458 | |
| MousePheno | abnormal articular cartilage morphology | 6.08e-04 | 14 | 37 | 2 | MP:0006433 | |
| MousePheno | kidney hemorrhage | 6.08e-04 | 14 | 37 | 2 | MP:0000533 | |
| MousePheno | increased urine protein level | 6.23e-04 | 149 | 37 | 4 | MP:0002962 | |
| MousePheno | abnormal kidney interstitium morphology | 7.28e-04 | 67 | 37 | 3 | MP:0011425 | |
| MousePheno | abnormal long bone epiphyseal plate proliferative zone | 7.60e-04 | 68 | 37 | 3 | MP:0003662 | |
| MousePheno | glomerulosclerosis | 7.60e-04 | 68 | 37 | 3 | MP:0005264 | |
| MousePheno | abnormal joint mobility | 9.04e-04 | 17 | 37 | 2 | MP:0008069 | |
| MousePheno | abnormal forehead shape | 9.04e-04 | 17 | 37 | 2 | MP:0030045 | |
| MousePheno | abnormal kidney vasculature morphology | 9.35e-04 | 73 | 37 | 3 | MP:0000530 | |
| MousePheno | chondrodystrophy | 1.02e-03 | 18 | 37 | 2 | MP:0002657 | |
| MousePheno | abnormal urine protein level | 1.02e-03 | 170 | 37 | 4 | MP:0006315 | |
| MousePheno | kidney inflammation | 1.04e-03 | 171 | 37 | 4 | MP:0001859 | |
| MousePheno | abnormal long bone epiphyseal plate morphology | 1.06e-03 | 172 | 37 | 4 | MP:0003055 | |
| MousePheno | renal fibrosis | 1.13e-03 | 78 | 37 | 3 | MP:0003985 | |
| MousePheno | glomerular crescent | 1.13e-03 | 19 | 37 | 2 | MP:0011506 | |
| MousePheno | abnormal hindlimb joint morphology | 1.26e-03 | 20 | 37 | 2 | MP:0030808 | |
| MousePheno | abnormal lens capsule morphology | 1.26e-03 | 20 | 37 | 2 | MP:0003236 | |
| MousePheno | renal/urinary system inflammation | 1.26e-03 | 180 | 37 | 4 | MP:0011762 | |
| MousePheno | abnormal epiphyseal plate morphology | 1.39e-03 | 185 | 37 | 4 | MP:0006395 | |
| MousePheno | polyuria | 1.66e-03 | 89 | 37 | 3 | MP:0001762 | |
| MousePheno | abnormal knee morphology | 1.67e-03 | 23 | 37 | 2 | MP:0030881 | |
| MousePheno | abnormal long bone morphology | 1.73e-03 | 676 | 37 | 7 | MP:0003723 | |
| MousePheno | insulin resistance | 1.76e-03 | 197 | 37 | 4 | MP:0005331 | |
| MousePheno | tubulointerstitial nephritis | 1.81e-03 | 24 | 37 | 2 | MP:0011405 | |
| MousePheno | abnormal forehead morphology | 1.81e-03 | 24 | 37 | 2 | MP:0030031 | |
| MousePheno | abnormal anterior uvea morphology | 1.82e-03 | 199 | 37 | 4 | MP:0005194 | |
| MousePheno | disorganized long bone epiphyseal plate | 1.97e-03 | 25 | 37 | 2 | MP:0006397 | |
| MousePheno | abnormal hypothalamus physiology | 2.13e-03 | 26 | 37 | 2 | MP:0005645 | |
| MousePheno | decreased skin tensile strength | 2.13e-03 | 26 | 37 | 2 | MP:0003089 | |
| MousePheno | increased triglyceride level | 2.27e-03 | 354 | 37 | 5 | MP:0005317 | |
| MousePheno | abnormal bone marrow cavity morphology | 2.30e-03 | 27 | 37 | 2 | MP:0000065 | |
| MousePheno | abnormal extracellular matrix morphology | 2.31e-03 | 100 | 37 | 3 | MP:0013258 | |
| MousePheno | dilated renal tubule | 2.38e-03 | 101 | 37 | 3 | MP:0002705 | |
| MousePheno | increased mesangial cell number | 2.65e-03 | 29 | 37 | 2 | MP:0011427 | |
| MousePheno | shortened head | 2.65e-03 | 29 | 37 | 2 | MP:0000435 | |
| MousePheno | impaired hearing | 2.76e-03 | 223 | 37 | 4 | MP:0006325 | |
| MousePheno | abnormal kidney physiology | 2.81e-03 | 372 | 37 | 5 | MP:0002136 | |
| MousePheno | abnormal dermal layer morphology | 2.88e-03 | 108 | 37 | 3 | MP:0001243 | |
| MousePheno | abnormal renal tubule morphology | 2.94e-03 | 227 | 37 | 4 | MP:0002703 | |
| MousePheno | abnormal tendon morphology | 3.02e-03 | 31 | 37 | 2 | MP:0005503 | |
| MousePheno | short limbs | 3.11e-03 | 111 | 37 | 3 | MP:0000547 | |
| MousePheno | abnormal skin tensile strength | 3.22e-03 | 32 | 37 | 2 | MP:0005275 | |
| MousePheno | obese | 3.27e-03 | 113 | 37 | 3 | MP:0001261 | |
| MousePheno | abnormal blood urea nitrogen level | 3.41e-03 | 389 | 37 | 5 | MP:0005265 | |
| MousePheno | abnormal uvea morphology | 3.64e-03 | 241 | 37 | 4 | MP:0005197 | |
| MousePheno | abnormal joint morphology | 3.71e-03 | 397 | 37 | 5 | MP:0002932 | |
| Domain | Collagen | COL2A1 MSR1 COL4A1 C1QTNF9B COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COLEC12 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 OTOL1 COL6A5 COL9A2 C1QTNF2 COL11A1 COL22A1 COL11A2 GLDN COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 SCARA3 COL28A1 COL27A1 C1QTNF9 COL1A2 | 5.69e-75 | 85 | 48 | 35 | PF01391 |
| Domain | Collagen | COL2A1 MSR1 COL4A1 C1QTNF9B COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COLEC12 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 OTOL1 COL6A5 COL9A2 C1QTNF2 COL11A1 COL22A1 COL11A2 GLDN COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 SCARA3 COL28A1 COL27A1 C1QTNF9 COL1A2 | 5.69e-75 | 85 | 48 | 35 | IPR008160 |
| Domain | TSPN | COL5A1 COL24A1 COL5A3 COL14A1 COL11A1 COL22A1 COL11A2 COL15A1 COL16A1 COL19A1 COL21A1 COL27A1 | 2.46e-26 | 23 | 48 | 12 | SM00210 |
| Domain | Laminin_G | COL5A1 COL24A1 COL5A3 COL14A1 COL11A1 COL22A1 COL11A2 COL15A1 COL16A1 COL19A1 COL21A1 COL27A1 | 1.53e-20 | 58 | 48 | 12 | IPR001791 |
| Domain | NC1_FIB | 1.69e-19 | 11 | 48 | 8 | PS51461 | |
| Domain | Fib_collagen_C | 1.69e-19 | 11 | 48 | 8 | IPR000885 | |
| Domain | Fib_collagen_C | 1.69e-19 | 11 | 48 | 8 | PD002078 | |
| Domain | COLFI | 1.69e-19 | 11 | 48 | 8 | SM00038 | |
| Domain | COLFI | 1.69e-19 | 11 | 48 | 8 | PF01410 | |
| Domain | ConA-like_dom | COL5A1 COL24A1 COL5A3 COL14A1 COL11A1 COL22A1 COL11A2 COL15A1 COL16A1 COL19A1 ZAN COL21A1 COL27A1 | 7.44e-15 | 219 | 48 | 13 | IPR013320 |
| Domain | C4 | 5.42e-13 | 6 | 48 | 5 | SM00111 | |
| Domain | - | 5.42e-13 | 6 | 48 | 5 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 5.42e-13 | 6 | 48 | 5 | IPR001442 | |
| Domain | NC1_IV | 5.42e-13 | 6 | 48 | 5 | PS51403 | |
| Domain | C4 | 5.42e-13 | 6 | 48 | 5 | PF01413 | |
| Domain | VWA | 1.33e-12 | 56 | 48 | 8 | PF00092 | |
| Domain | - | 1.37e-11 | 74 | 48 | 8 | 3.40.50.410 | |
| Domain | VWFA | 3.18e-11 | 82 | 48 | 8 | PS50234 | |
| Domain | VWA | 3.88e-11 | 84 | 48 | 8 | SM00327 | |
| Domain | - | COL5A1 COL24A1 COL5A3 COL11A1 COL11A2 COL16A1 COL19A1 COL21A1 | 1.06e-10 | 95 | 48 | 8 | 2.60.120.200 |
| Domain | VWF_A | 1.48e-10 | 99 | 48 | 8 | IPR002035 | |
| Domain | CTDL_fold | 1.01e-08 | 107 | 48 | 7 | IPR016187 | |
| Domain | Laminin_G_2 | 5.57e-08 | 40 | 48 | 5 | PF02210 | |
| Domain | LamG | 9.12e-08 | 44 | 48 | 5 | SM00282 | |
| Domain | C1Q | 1.31e-06 | 32 | 48 | 4 | SM00110 | |
| Domain | C1q | 1.31e-06 | 32 | 48 | 4 | PF00386 | |
| Domain | C1q_dom | 1.68e-06 | 34 | 48 | 4 | IPR001073 | |
| Domain | C1Q | 1.68e-06 | 34 | 48 | 4 | PS50871 | |
| Domain | - | 8.11e-06 | 50 | 48 | 4 | 2.60.120.40 | |
| Domain | Tumour_necrosis_fac-like_dom | 1.47e-05 | 58 | 48 | 4 | IPR008983 | |
| Domain | LAM_G_DOMAIN | 1.26e-04 | 38 | 48 | 3 | PS50025 | |
| Domain | - | 9.64e-04 | 18 | 48 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 9.64e-04 | 18 | 48 | 2 | IPR020901 | |
| Domain | BPTI_KUNITZ_2 | 1.08e-03 | 19 | 48 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 1.08e-03 | 19 | 48 | 2 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 1.08e-03 | 19 | 48 | 2 | PS00280 | |
| Domain | Kunitz_BPTI | 1.58e-03 | 23 | 48 | 2 | IPR002223 | |
| Domain | VWFC_1 | 3.85e-03 | 36 | 48 | 2 | PS01208 | |
| Domain | VWC | 4.29e-03 | 38 | 48 | 2 | SM00214 | |
| Domain | VWFC_2 | 4.29e-03 | 38 | 48 | 2 | PS50184 | |
| Domain | VWF_dom | 5.22e-03 | 42 | 48 | 2 | IPR001007 | |
| Domain | FERM_M | 6.23e-03 | 46 | 48 | 2 | PF00373 | |
| Domain | FERM_central | 7.04e-03 | 49 | 48 | 2 | IPR019748 | |
| Domain | FERM_domain | 7.04e-03 | 49 | 48 | 2 | IPR000299 | |
| Domain | FERM_1 | 7.32e-03 | 50 | 48 | 2 | PS00660 | |
| Domain | FERM_2 | 7.32e-03 | 50 | 48 | 2 | PS00661 | |
| Domain | Band_41_domain | 7.32e-03 | 50 | 48 | 2 | IPR019749 | |
| Domain | B41 | 7.32e-03 | 50 | 48 | 2 | SM00295 | |
| Domain | FERM_3 | 7.32e-03 | 50 | 48 | 2 | PS50057 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 COL28A1 COL27A1 COL1A2 | 8.55e-63 | 44 | 40 | 27 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 COL28A1 COL27A1 COL1A2 | 5.01e-56 | 67 | 40 | 27 | M26999 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL28A1 COL1A2 | 1.56e-54 | 41 | 40 | 24 | MM15538 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 COL28A1 COL27A1 COL1A2 | 8.22e-52 | 90 | 40 | 27 | M631 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL28A1 COL1A2 | 5.98e-49 | 61 | 40 | 24 | MM14637 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL28A1 COL1A2 | 3.73e-46 | 76 | 40 | 24 | MM14573 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL1A2 | 5.18e-43 | 64 | 40 | 22 | M26953 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL11A2 COL15A1 COL6A6 COL27A1 COL1A2 | 2.09e-38 | 61 | 40 | 20 | M27103 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 COL28A1 COL27A1 COL1A2 | 2.07e-36 | 300 | 40 | 27 | M610 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL11A2 COL15A1 COL6A6 COL1A2 | 2.61e-35 | 50 | 40 | 18 | MM14796 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL5A3 COL7A1 COL6A5 COL11A1 COL11A2 COL13A1 COL15A1 COL19A1 COL6A6 COL1A2 | 9.31e-35 | 53 | 40 | 18 | MM14566 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL1A2 | 1.50e-34 | 140 | 40 | 22 | M587 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL1A2 | 1.55e-33 | 46 | 40 | 17 | M198 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL28A1 COL1A2 | 3.28e-32 | 258 | 40 | 24 | MM14572 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL1A2 | 1.95e-29 | 74 | 40 | 17 | M160 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL5A3 COL7A1 COL6A5 COL9A2 COL13A1 COL16A1 COL6A6 COL1A2 | 2.67e-28 | 85 | 40 | 17 | M16441 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL5A3 COL7A1 COL6A5 COL11A1 COL11A2 COL13A1 COL15A1 COL19A1 COL6A6 COL1A2 | 5.27e-28 | 114 | 40 | 18 | MM14571 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL5A3 COL7A1 COL6A5 COL9A2 COL13A1 COL16A1 COL6A6 COL1A2 | 5.36e-27 | 76 | 40 | 16 | MM14867 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A2 COL5A3 COL6A5 COL9A2 COL6A6 | 3.50e-24 | 20 | 40 | 11 | MM15061 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A3 COL11A1 COL11A2 COL1A2 | 2.63e-21 | 32 | 40 | 11 | MM14924 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL5A3 COL6A5 COL9A2 COL6A6 COL1A2 | 1.18e-20 | 76 | 40 | 13 | M27219 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A2 COL5A3 COL6A5 COL9A2 COL6A6 | 2.42e-20 | 38 | 40 | 11 | MM14969 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A2 COL5A3 COL6A5 COL9A2 COL6A6 | 8.56e-20 | 42 | 40 | 11 | M7169 |
| Pathway | PID_INTEGRIN1_PATHWAY | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL11A1 COL11A2 COL1A2 | 1.95e-19 | 66 | 40 | 12 | M18 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A2 COL5A3 COL6A5 COL9A2 COL6A6 | 3.59e-18 | 57 | 40 | 11 | MM14713 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A2 COL5A3 COL6A5 COL9A2 COL6A6 | 4.42e-18 | 58 | 40 | 11 | M2049 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A3 COL11A1 COL11A2 COL1A2 | 5.42e-18 | 59 | 40 | 11 | M27218 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A2 COL5A3 COL6A5 COL9A2 COL6A6 | 1.18e-17 | 63 | 40 | 11 | M11187 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | COL2A1 COL4A1 COL4A4 COL4A6 COL5A1 COL6A2 COL5A3 COL11A1 COL11A2 COL6A6 COL1A2 | 3.43e-16 | 84 | 40 | 11 | M7098 |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 5.38e-15 | 15 | 40 | 7 | M27161 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.12e-14 | 30 | 40 | 8 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.78e-13 | 41 | 40 | 8 | M27778 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL5A1 COL24A1 COL6A2 COL5A3 COL6A5 COL9A2 COL11A1 COL11A2 COL6A6 COL27A1 COL1A2 | 3.68e-13 | 532 | 40 | 16 | M27870 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.79e-13 | 47 | 40 | 8 | MM14925 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A2 COL5A3 COL6A5 COL9A2 COL11A1 COL11A2 COL6A6 COL1A2 | 3.76e-12 | 418 | 40 | 14 | MM15587 |
| Pathway | KEGG_FOCAL_ADHESION | COL2A1 COL4A1 COL4A4 COL4A6 COL5A1 COL6A2 COL5A3 COL11A1 COL11A2 COL6A6 COL1A2 | 5.44e-12 | 199 | 40 | 11 | M7253 |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 6.38e-12 | 18 | 40 | 6 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 6.38e-12 | 18 | 40 | 6 | MM14882 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 9.31e-12 | 19 | 40 | 6 | MM15512 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 3.54e-11 | 10 | 40 | 5 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 3.54e-11 | 10 | 40 | 5 | MM1560 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 4.50e-11 | 79 | 40 | 8 | M27643 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 6.48e-11 | 11 | 40 | 5 | M15422 | |
| Pathway | WP_FOCAL_ADHESION | COL2A1 COL4A1 COL4A4 COL4A6 COL5A1 COL6A2 COL5A3 COL11A1 COL11A2 COL1A2 | 7.96e-11 | 187 | 40 | 10 | MM15913 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A2 COL5A3 COL6A5 COL9A2 COL6A6 | 1.02e-10 | 261 | 40 | 11 | MM15676 |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.11e-10 | 12 | 40 | 5 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.80e-10 | 13 | 40 | 5 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.80e-10 | 13 | 40 | 5 | M12950 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.99e-10 | 30 | 40 | 6 | M27216 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.99e-10 | 30 | 40 | 6 | MM15517 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.79e-10 | 14 | 40 | 5 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.79e-10 | 14 | 40 | 5 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.17e-10 | 15 | 40 | 5 | MM14922 | |
| Pathway | WP_PI3KAKT_SIGNALING | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL6A2 COL6A5 COL9A2 COL6A6 COL1A2 | 1.64e-09 | 339 | 40 | 11 | M39736 |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.99e-09 | 43 | 40 | 6 | M53 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 2.13e-09 | 20 | 40 | 5 | M15394 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 4.60e-09 | 23 | 40 | 5 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 4.60e-09 | 23 | 40 | 5 | MM1427 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | COL2A1 COL4A1 COL4A4 COL4A6 COL5A1 COL6A2 COL5A3 COL11A1 COL11A2 COL1A2 | 8.42e-09 | 302 | 40 | 10 | M39719 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | COL2A1 COL4A1 COL4A4 COL4A6 COL5A1 COL6A2 COL5A3 COL11A1 COL11A2 COL1A2 | 1.75e-08 | 326 | 40 | 10 | MM15917 |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.10e-08 | 67 | 40 | 6 | MM15345 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A2 COL5A3 COL6A5 COL9A2 COL6A6 | 9.49e-08 | 502 | 40 | 11 | MM14537 |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.26e-07 | 43 | 40 | 5 | M39565 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 2.09e-07 | 19 | 40 | 4 | M27221 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A2 COL5A3 COL6A5 COL9A2 COL6A6 | 3.72e-07 | 575 | 40 | 11 | M29853 |
| Pathway | WP_FOCAL_ADHESION | 1.26e-06 | 199 | 40 | 7 | M39402 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 7.18e-06 | 96 | 40 | 5 | M39834 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 5.91e-05 | 27 | 40 | 3 | M27217 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 8.70e-05 | 161 | 40 | 5 | M39770 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 1.66e-04 | 98 | 40 | 4 | M27152 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 2.77e-04 | 45 | 40 | 3 | M39864 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 1.10e-03 | 72 | 40 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 1.15e-03 | 73 | 40 | 3 | MM15906 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL5A1 COL6A2 COL5A3 COL6A5 COL9A2 COL6A6 | 1.64e-03 | 1432 | 40 | 11 | M509 |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 1.72e-03 | 84 | 40 | 3 | M3228 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 2.83e-03 | 28 | 40 | 2 | MM15957 | |
| Pathway | WP_13Q1212_COPY_NUMBER_VARIATION | 4.16e-03 | 34 | 40 | 2 | M48103 | |
| Pathway | WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME | 4.40e-03 | 35 | 40 | 2 | M45521 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 5.17e-03 | 38 | 40 | 2 | MM15456 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 5.44e-03 | 39 | 40 | 2 | M10735 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 7.68e-03 | 439 | 40 | 5 | M42563 | |
| Pathway | WP_CANCER_PATHWAYS | 1.37e-02 | 507 | 40 | 5 | M48302 | |
| Pubmed | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL15A1 COL16A1 COL6A6 COL28A1 COL27A1 COL1A2 | 8.54e-41 | 175 | 48 | 23 | 28071719 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL6A6 COL21A1 COL28A1 COL1A2 | 9.36e-39 | 135 | 48 | 21 | 28675934 |
| Pubmed | COL4A1 COL23A1 COL4A3 COL4A4 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 COL28A1 COL1A2 | 5.45e-33 | 153 | 48 | 19 | 25037231 | |
| Pubmed | COL4A1 COL23A1 COL4A4 COL4A5 COL4A6 COL5A1 COLEC12 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL13A1 COL15A1 COL16A1 COL28A1 COL27A1 COL1A2 | 3.15e-32 | 167 | 48 | 19 | 22159717 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL2A1 COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL5A3 COL7A1 COL6A5 COL11A2 COL16A1 COL27A1 COL1A2 | 3.10e-28 | 62 | 48 | 14 | 28344315 |
| Pubmed | COL2A1 COL23A1 COL4A3 COL4A6 COL5A1 COL6A2 COL5A3 COL7A1 COL9A2 COL11A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL1A2 | 3.32e-24 | 210 | 48 | 16 | 16537572 | |
| Pubmed | COL2A1 COL4A1 COL23A1 COL4A5 COL14A1 COL7A1 COL11A1 COL13A1 COL15A1 COL16A1 | 5.67e-21 | 39 | 48 | 10 | 33580754 | |
| Pubmed | 1.40e-16 | 8 | 48 | 6 | 10382266 | ||
| Pubmed | 1.40e-16 | 8 | 48 | 6 | 3997552 | ||
| Pubmed | 3.00e-16 | 19 | 48 | 7 | 15689378 | ||
| Pubmed | 4.18e-16 | 9 | 48 | 6 | 9878537 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | COL2A1 COL4A1 COL5A1 COL6A2 COL5A3 COL15A1 COL6A6 COL28A1 COL1A2 | 1.07e-14 | 97 | 48 | 9 | 27559042 |
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 2.42e-14 | 6 | 48 | 5 | 10534397 | |
| Pubmed | 2.42e-14 | 6 | 48 | 5 | 10722718 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 2.42e-14 | 6 | 48 | 5 | 9506531 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 2.42e-14 | 6 | 48 | 5 | 9673377 | |
| Pubmed | 2.42e-14 | 6 | 48 | 5 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 2.42e-14 | 6 | 48 | 5 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 2.42e-14 | 6 | 48 | 5 | 6811420 | |
| Pubmed | 2.42e-14 | 6 | 48 | 5 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 2.42e-14 | 6 | 48 | 5 | 19275937 | |
| Pubmed | 2.42e-14 | 6 | 48 | 5 | 6988303 | ||
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 2.42e-14 | 6 | 48 | 5 | 6389236 | |
| Pubmed | 2.42e-14 | 6 | 48 | 5 | 12225806 | ||
| Pubmed | 8.46e-14 | 7 | 48 | 5 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 8.46e-14 | 7 | 48 | 5 | 8006028 | |
| Pubmed | 8.46e-14 | 7 | 48 | 5 | 10416788 | ||
| Pubmed | 8.46e-14 | 7 | 48 | 5 | 1724753 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 2.25e-13 | 8 | 48 | 5 | 20059976 | |
| Pubmed | 2.25e-13 | 8 | 48 | 5 | 29422532 | ||
| Pubmed | 2.25e-13 | 8 | 48 | 5 | 1377218 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 3.48e-13 | 86 | 48 | 8 | 28327460 | |
| Pubmed | 5.07e-13 | 9 | 48 | 5 | 12101409 | ||
| Pubmed | 8.67e-13 | 25 | 48 | 6 | 19180518 | ||
| Pubmed | 1.01e-12 | 10 | 48 | 5 | 9136074 | ||
| Pubmed | 1.01e-12 | 10 | 48 | 5 | 9415455 | ||
| Pubmed | 1.85e-12 | 11 | 48 | 5 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 1.85e-12 | 11 | 48 | 5 | 7500359 | |
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 3.18e-12 | 12 | 48 | 5 | 15837576 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 3.18e-12 | 12 | 48 | 5 | 12180907 | |
| Pubmed | 3.18e-12 | 12 | 48 | 5 | 16024816 | ||
| Pubmed | Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. | 3.19e-12 | 4 | 48 | 4 | 17683922 | |
| Pubmed | 8.01e-12 | 14 | 48 | 5 | 12878203 | ||
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 1.20e-11 | 15 | 48 | 5 | 9832566 | |
| Pubmed | 1.59e-11 | 5 | 48 | 4 | 9409248 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.62e-11 | 79 | 48 | 7 | 18757743 | |
| Pubmed | 1.74e-11 | 16 | 48 | 5 | 15878328 | ||
| Pubmed | 2.60e-11 | 146 | 48 | 8 | 27068509 | ||
| Pubmed | 4.78e-11 | 6 | 48 | 4 | 21467034 | ||
| Pubmed | 4.78e-11 | 6 | 48 | 4 | 7495302 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 4.78e-11 | 6 | 48 | 4 | 8563024 | |
| Pubmed | 4.78e-11 | 6 | 48 | 4 | 17876790 | ||
| Pubmed | 4.78e-11 | 6 | 48 | 4 | 15922184 | ||
| Pubmed | 4.78e-11 | 6 | 48 | 4 | 20301479 | ||
| Pubmed | 1.11e-10 | 7 | 48 | 4 | 10639489 | ||
| Pubmed | 1.11e-10 | 7 | 48 | 4 | 7521231 | ||
| Pubmed | 1.11e-10 | 7 | 48 | 4 | 17418794 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 1.11e-10 | 7 | 48 | 4 | 10716744 | |
| Pubmed | 1.68e-10 | 24 | 48 | 5 | 25344368 | ||
| Pubmed | 2.23e-10 | 8 | 48 | 4 | 18816857 | ||
| Pubmed | 2.23e-10 | 8 | 48 | 4 | 15872058 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 2.23e-10 | 8 | 48 | 4 | 10970885 | |
| Pubmed | 2.23e-10 | 8 | 48 | 4 | 1383086 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 2.23e-10 | 8 | 48 | 4 | 11867580 | |
| Pubmed | 2.60e-10 | 26 | 48 | 5 | 24742657 | ||
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 3.19e-10 | 27 | 48 | 5 | 12192060 | |
| Pubmed | 3.53e-10 | 64 | 48 | 6 | 22261194 | ||
| Pubmed | 4.00e-10 | 9 | 48 | 4 | 8562707 | ||
| Pubmed | 4.00e-10 | 9 | 48 | 4 | 8900172 | ||
| Pubmed | 6.66e-10 | 10 | 48 | 4 | 2446864 | ||
| Pubmed | 6.68e-10 | 31 | 48 | 5 | 22925884 | ||
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 1.05e-09 | 11 | 48 | 4 | 9731539 | |
| Pubmed | 1.57e-09 | 12 | 48 | 4 | 8918877 | ||
| Pubmed | 1.96e-09 | 38 | 48 | 5 | 25572963 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 2.26e-09 | 13 | 48 | 4 | 9833687 | |
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 2.47e-09 | 3 | 48 | 3 | 27576055 | |
| Pubmed | Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. | 2.47e-09 | 3 | 48 | 3 | 15954103 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 36130833 | ||
| Pubmed | Collagen mRNA levels changes during colorectal cancer carcinogenesis. | 2.47e-09 | 3 | 48 | 3 | 19422682 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 14507670 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 6501291 | ||
| Pubmed | Genetic diagnosis of Alport syndrome in 16 Chinese families. | 2.47e-09 | 3 | 48 | 3 | 38433557 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 15908193 | ||
| Pubmed | Alport syndrome: impact of digenic inheritance in patients management. | 2.47e-09 | 3 | 48 | 3 | 27859054 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 25575550 | ||
| Pubmed | COL4A6 is dispensable for autosomal recessive Alport syndrome. | 2.47e-09 | 3 | 48 | 3 | 27377778 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 17396119 | ||
| Pubmed | Identification of an Altered Matrix Signature in Kidney Aging and Disease. | 2.47e-09 | 3 | 48 | 3 | 34049963 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 24522496 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 6386565 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 7962065 | ||
| Pubmed | Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome. | 2.47e-09 | 3 | 48 | 3 | 28542346 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 7346227 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 28704582 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 15141750 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 18930919 | ||
| Pubmed | Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. | 2.47e-09 | 3 | 48 | 3 | 30647093 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 34009784 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 38978054 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 24033287 | ||
| Interaction | COLGALT2 interactions | COL2A1 MSR1 COL4A1 C1QTNF9B COL4A5 COL6A2 COL9A2 C1QTNF2 COL13A1 COL16A1 COL21A1 C1QTNF9 | 2.29e-20 | 67 | 46 | 12 | int:COLGALT2 |
| Interaction | MMP9 interactions | COL2A1 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COLEC12 COL6A2 COL14A1 SCARA3 COL1A2 | 2.29e-20 | 67 | 46 | 12 | int:MMP9 |
| Interaction | LAIR2 interactions | COL2A1 COL4A1 COL4A4 COL4A6 COL5A1 COLEC12 COL6A2 COL14A1 COL13A1 SCARA3 | 1.03e-17 | 49 | 46 | 10 | int:LAIR2 |
| Interaction | C1QTNF1 interactions | COL2A1 COL4A1 COL4A6 COL5A1 COLEC12 COL6A2 COL14A1 COL21A1 SCARA3 | 9.35e-16 | 47 | 46 | 9 | int:C1QTNF1 |
| Interaction | DCN interactions | 5.29e-14 | 43 | 46 | 8 | int:DCN | |
| Interaction | PLOD1 interactions | COL2A1 COL4A1 COL23A1 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL14A1 COL13A1 COL16A1 COL21A1 SCARA3 | 6.30e-14 | 292 | 46 | 13 | int:PLOD1 |
| Interaction | MMP2 interactions | COL2A1 COL4A1 COL4A6 COL5A1 COLEC12 COL6A2 COL14A1 COL7A1 COL1A2 | 3.29e-13 | 87 | 46 | 9 | int:MMP2 |
| Interaction | COL2A1 interactions | COL2A1 COL4A1 C1QTNF9B COL9A2 C1QTNF2 COL11A1 COL16A1 C1QTNF9 | 1.56e-12 | 64 | 46 | 8 | int:COL2A1 |
| Interaction | COL8A2 interactions | 5.09e-12 | 42 | 46 | 7 | int:COL8A2 | |
| Interaction | PLOD3 interactions | COL4A1 C1QTNF9B COL23A1 COL4A6 COL6A2 COL9A2 COL13A1 COL16A1 COL21A1 SCARA3 | 9.14e-12 | 183 | 46 | 10 | int:PLOD3 |
| Interaction | COL4A2 interactions | 3.54e-10 | 75 | 46 | 7 | int:COL4A2 | |
| Interaction | HABP2 interactions | 4.15e-10 | 18 | 46 | 5 | int:HABP2 | |
| Interaction | OSM interactions | 7.48e-10 | 20 | 46 | 5 | int:OSM | |
| Interaction | CD93 interactions | 7.68e-10 | 45 | 46 | 6 | int:CD93 | |
| Interaction | COL6A2 interactions | 1.30e-09 | 90 | 46 | 7 | int:COL6A2 | |
| Interaction | COL14A1 interactions | 1.30e-09 | 90 | 46 | 7 | int:COL14A1 | |
| Interaction | C1QTNF9B interactions | 1.68e-09 | 51 | 46 | 6 | int:C1QTNF9B | |
| Interaction | TGFBI interactions | 2.54e-09 | 25 | 46 | 5 | int:TGFBI | |
| Interaction | SERPINE2 interactions | 3.00e-09 | 56 | 46 | 6 | int:SERPINE2 | |
| Interaction | C1QTNF2 interactions | 5.63e-09 | 62 | 46 | 6 | int:C1QTNF2 | |
| Interaction | COL11A1 interactions | 5.64e-09 | 29 | 46 | 5 | int:COL11A1 | |
| Interaction | PDGFA interactions | 9.52e-09 | 32 | 46 | 5 | int:PDGFA | |
| Interaction | C1QTNF9 interactions | 2.04e-08 | 37 | 46 | 5 | int:C1QTNF9 | |
| Interaction | COL16A1 interactions | 7.10e-08 | 18 | 46 | 4 | int:COL16A1 | |
| Interaction | SPARC interactions | 3.69e-07 | 65 | 46 | 5 | int:SPARC | |
| Interaction | FBLN2 interactions | 3.99e-07 | 66 | 46 | 5 | int:FBLN2 | |
| Interaction | MAG interactions | 5.41e-07 | 29 | 46 | 4 | int:MAG | |
| Interaction | BGN interactions | 6.23e-07 | 30 | 46 | 4 | int:BGN | |
| Interaction | COL5A3 interactions | 1.32e-06 | 10 | 46 | 3 | int:COL5A3 | |
| Interaction | FN1 interactions | COL2A1 CKAP5 COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL6A2 COL7A1 COL13A1 COL1A2 | 2.37e-06 | 848 | 46 | 11 | int:FN1 |
| Interaction | C1QC interactions | 2.50e-06 | 42 | 46 | 4 | int:C1QC | |
| Interaction | COL12A1 interactions | 5.07e-06 | 50 | 46 | 4 | int:COL12A1 | |
| Interaction | MATN2 interactions | 5.79e-06 | 113 | 46 | 5 | int:MATN2 | |
| Interaction | SAA1 interactions | 6.91e-06 | 54 | 46 | 4 | int:SAA1 | |
| Interaction | THBS1 interactions | 1.02e-05 | 127 | 46 | 5 | int:THBS1 | |
| Interaction | COL5A1 interactions | 1.45e-05 | 65 | 46 | 4 | int:COL5A1 | |
| Interaction | ANTXR2 interactions | 3.90e-05 | 29 | 46 | 3 | int:ANTXR2 | |
| Interaction | PDGFB interactions | 4.81e-05 | 88 | 46 | 4 | int:PDGFB | |
| Interaction | PRELP interactions | 5.27e-05 | 32 | 46 | 3 | int:PRELP | |
| Interaction | PLOD2 interactions | 5.48e-05 | 180 | 46 | 5 | int:PLOD2 | |
| Interaction | COL6A1 interactions | 1.46e-04 | 117 | 46 | 4 | int:COL6A1 | |
| Interaction | NID1 interactions | 1.79e-04 | 48 | 46 | 3 | int:NID1 | |
| Interaction | COL4A1 interactions | 1.79e-04 | 48 | 46 | 3 | int:COL4A1 | |
| Interaction | ADAMTS5 interactions | 1.82e-04 | 9 | 46 | 2 | int:ADAMTS5 | |
| Interaction | COL21A1 interactions | 1.82e-04 | 9 | 46 | 2 | int:COL21A1 | |
| Interaction | COL8A1 interactions | 2.25e-04 | 131 | 46 | 4 | int:COL8A1 | |
| Interaction | PCOLCE interactions | 2.77e-04 | 11 | 46 | 2 | int:PCOLCE | |
| Interaction | COL9A1 interactions | 3.91e-04 | 13 | 46 | 2 | int:COL9A1 | |
| Interaction | COLEC12 interactions | 5.03e-04 | 68 | 46 | 3 | int:COLEC12 | |
| Interaction | P4HA1 interactions | 5.70e-04 | 298 | 46 | 5 | int:P4HA1 | |
| Interaction | C1QL4 interactions | 6.19e-04 | 73 | 46 | 3 | int:C1QL4 | |
| Interaction | COL9A2 interactions | 6.78e-04 | 17 | 46 | 2 | int:COL9A2 | |
| Interaction | COL1A2 interactions | 7.51e-04 | 78 | 46 | 3 | int:COL1A2 | |
| Interaction | COMP interactions | 9.43e-04 | 20 | 46 | 2 | int:COMP | |
| Interaction | CBLL2 interactions | 9.43e-04 | 20 | 46 | 2 | int:CBLL2 | |
| Interaction | P3H3 interactions | 1.03e-03 | 87 | 46 | 3 | int:P3H3 | |
| Interaction | PRNP interactions | COL4A4 COLEC12 COL24A1 COL9A2 COL11A1 COL22A1 COL13A1 COL16A1 COL1A2 | 1.06e-03 | 1158 | 46 | 9 | int:PRNP |
| Interaction | SCARA3 interactions | 1.14e-03 | 90 | 46 | 3 | int:SCARA3 | |
| Cytoband | Xq22 | 1.63e-06 | 22 | 48 | 3 | Xq22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq22 | 3.25e-05 | 172 | 48 | 4 | chrXq22 | |
| Cytoband | 13q12.12 | 2.67e-04 | 23 | 48 | 2 | 13q12.12 | |
| Cytoband | 3q22.1 | 8.97e-04 | 42 | 48 | 2 | 3q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q36 | 3.62e-03 | 85 | 48 | 2 | chr2q36 | |
| GeneFamily | Collagens | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 COL28A1 COL27A1 COL1A2 | 5.09e-64 | 46 | 42 | 27 | 490 |
| GeneFamily | Endogenous ligands|C1q and TNF related | 7.52e-08 | 18 | 42 | 4 | 1372 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 3.28e-05 | 27 | 42 | 3 | 1253 | |
| GeneFamily | Collagens|Collagen proteoglycans | 5.24e-05 | 5 | 42 | 2 | 575 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 6.01e-03 | 50 | 42 | 2 | 1293 | |
| Coexpression | NABA_COLLAGENS | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 COL28A1 COL27A1 COL1A2 | 8.38e-67 | 44 | 48 | 27 | M3005 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL28A1 COL27A1 COL1A2 | 6.12e-64 | 43 | 48 | 26 | MM17060 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 OTOL1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 GLDN COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 COL28A1 COL27A1 COL1A2 | 8.59e-46 | 275 | 48 | 29 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A1 COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 OTOL1 COL6A5 COL9A2 COL11A1 COL22A1 COL11A2 GLDN COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL28A1 COL27A1 COL1A2 | 7.64e-44 | 270 | 48 | 28 | MM17057 |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A1 C1QTNF9B COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COLEC12 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 OTOL1 COL6A5 COL9A2 C1QTNF2 COL11A1 COL22A1 COL11A2 GLDN COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL21A1 COL28A1 COL27A1 C1QTNF9 COL1A2 | 1.36e-35 | 1026 | 48 | 33 | M5889 |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A1 C1QTNF9B COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COLEC12 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 OTOL1 COL6A5 COL9A2 C1QTNF2 COL11A1 COL22A1 COL11A2 GLDN COL13A1 COL15A1 COL16A1 COL19A1 COL6A6 COL28A1 COL27A1 C1QTNF9 COL1A2 | 4.06e-34 | 1008 | 48 | 32 | MM17056 |
| Coexpression | NABA_BASEMENT_MEMBRANES | COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL6A2 COL6A5 COL15A1 COL6A6 | 2.74e-17 | 40 | 48 | 9 | M5887 |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | COL5A1 COL6A2 COL14A1 C1QTNF2 COL15A1 COL16A1 COL6A6 COL21A1 COL1A2 | 7.46e-13 | 117 | 48 | 9 | M39300 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.25e-11 | 29 | 48 | 6 | MM17055 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | COL4A1 COL4A5 COL5A1 COL5A3 COL14A1 COL15A1 COL16A1 COL19A1 COL28A1 COL27A1 | 4.91e-11 | 268 | 48 | 10 | M45796 |
| Coexpression | GU_PDEF_TARGETS_UP | 5.32e-11 | 71 | 48 | 7 | M3955 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL4A1 COL4A5 COL4A6 COL5A1 COLEC12 COL6A2 COL5A3 COL14A1 COL13A1 COL15A1 COL27A1 COL1A2 | 8.53e-11 | 505 | 48 | 12 | M39167 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 5.45e-10 | 23 | 48 | 5 | M48001 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | MSR1 COL4A1 COL5A1 COLEC12 COL6A2 COL14A1 COL11A1 COL15A1 COL16A1 COL1A2 | 6.99e-10 | 352 | 48 | 10 | M17471 |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL4A1 COL5A1 COL6A2 COL5A3 COL14A1 COL7A1 COL11A1 GLDN COL16A1 COL21A1 SCARA3 COL28A1 COL1A2 | 7.82e-10 | 767 | 48 | 13 | M39209 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 1.29e-09 | 111 | 48 | 7 | M45685 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.90e-09 | 200 | 48 | 8 | M5930 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 3.24e-09 | 11 | 48 | 4 | M47997 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 2.69e-08 | 99 | 48 | 6 | M39152 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 3.31e-08 | 50 | 48 | 5 | MM403 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 1.26e-07 | 65 | 48 | 5 | M39309 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE | 1.59e-07 | 68 | 48 | 5 | M45669 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | COL4A1 COL4A6 COL5A1 COL14A1 COL7A1 COL13A1 COL16A1 COL27A1 COL1A2 | 2.40e-07 | 493 | 48 | 9 | M19391 |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 3.30e-07 | 369 | 48 | 8 | MM16610 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 4.65e-07 | 261 | 48 | 7 | M1834 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 4.97e-07 | 35 | 48 | 4 | MM17054 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 6.87e-07 | 91 | 48 | 5 | M40180 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL | 9.44e-07 | 97 | 48 | 5 | M45794 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | COL4A1 COL4A5 COL5A1 COL5A3 COL14A1 COL22A1 COL11A2 COL15A1 COL16A1 COL19A1 COL28A1 | 2.43e-06 | 1054 | 48 | 11 | M45798 |
| Coexpression | DESCARTES_ORGANOGENESIS_CONNECTIVE_TISSUE_PROGENITOR | 3.15e-06 | 55 | 48 | 4 | MM3666 | |
| Coexpression | RODWELL_AGING_KIDNEY_NO_BLOOD_UP | 3.31e-06 | 224 | 48 | 6 | M9893 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.85e-06 | 17 | 48 | 3 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.85e-06 | 17 | 48 | 3 | MM1297 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 3.85e-06 | 17 | 48 | 3 | M47995 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 4.61e-06 | 18 | 48 | 3 | M47984 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 5.18e-06 | 137 | 48 | 5 | M40313 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL | 5.62e-06 | 380 | 48 | 7 | M45714 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 5.80e-06 | 64 | 48 | 4 | M2572 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 6.12e-06 | 385 | 48 | 7 | M39264 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_STROMAL_CELLS | 7.07e-06 | 146 | 48 | 5 | M40222 | |
| Coexpression | DESCARTES_MAIN_FETAL_STROMAL_CELLS | 8.66e-06 | 22 | 48 | 3 | M40074 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.04e-05 | 74 | 48 | 4 | M13547 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 1.21e-05 | 163 | 48 | 5 | M2769 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER | 1.29e-05 | 25 | 48 | 3 | M47986 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 1.63e-05 | 27 | 48 | 3 | M47994 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 1.85e-05 | 178 | 48 | 5 | M17079 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 1.88e-05 | 86 | 48 | 4 | M2259 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.51e-05 | 479 | 48 | 7 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.65e-05 | 483 | 48 | 7 | MM1082 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 2.79e-05 | 194 | 48 | 5 | M39122 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 3.00e-05 | 681 | 48 | 8 | M39175 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 3.03e-05 | 33 | 48 | 3 | M9167 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS_TUMOR_CELL_DERIVED | 3.27e-05 | 5 | 48 | 2 | M47996 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 3.43e-05 | 503 | 48 | 7 | M2226 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.62e-05 | 35 | 48 | 3 | M11788 | |
| Coexpression | KIM_GLIS2_TARGETS_UP | 3.69e-05 | 102 | 48 | 4 | MM1064 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.94e-05 | 36 | 48 | 3 | MM1212 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 4.90e-05 | 6 | 48 | 2 | M48000 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 5.13e-05 | 111 | 48 | 4 | M1348 | |
| Coexpression | PEREZ_TP53_TARGETS | COL2A1 COL4A4 TSPYL5 COL22A1 GLDN COL13A1 COL15A1 CYSRT1 COL21A1 COL27A1 | 5.23e-05 | 1201 | 48 | 10 | M4391 |
| Coexpression | PILON_KLF1_TARGETS_UP | 5.43e-05 | 541 | 48 | 7 | MM1061 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS | 5.50e-05 | 113 | 48 | 4 | M43610 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 5.85e-05 | 41 | 48 | 3 | M47988 | |
| Coexpression | CUI_DEVELOPING_HEART_CORONARY_VASCULAR_ENDOTHELIAL_CELL | 5.85e-05 | 41 | 48 | 3 | M39320 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE | 6.30e-05 | 117 | 48 | 4 | M45663 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 6.94e-05 | 235 | 48 | 5 | M5311 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 8.15e-05 | 125 | 48 | 4 | M1969 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 8.41e-05 | 126 | 48 | 4 | M39132 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 8.83e-05 | 47 | 48 | 3 | M7585 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 8.94e-05 | 128 | 48 | 4 | MM1000 | |
| Coexpression | CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL | 9.41e-05 | 48 | 48 | 3 | M39318 | |
| Coexpression | RB_P107_DN.V1_UP | 9.49e-05 | 130 | 48 | 4 | M2802 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 1.01e-04 | 132 | 48 | 4 | MM841 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 1.41e-04 | 144 | 48 | 4 | M1484 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 1.57e-04 | 148 | 48 | 4 | MM1010 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL | 1.61e-04 | 149 | 48 | 4 | M45703 | |
| Coexpression | BENPORATH_PRC2_TARGETS | 1.70e-04 | 650 | 48 | 7 | M8448 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 1.74e-04 | 59 | 48 | 3 | M47993 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 1.79e-04 | 457 | 48 | 6 | M1613 | |
| Coexpression | NABA_ECM_AFFILIATED | 2.01e-04 | 158 | 48 | 4 | MM17063 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 2.02e-04 | 62 | 48 | 3 | M16774 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 2.09e-04 | 470 | 48 | 6 | MM1053 | |
| Coexpression | DESCARTES_ORGANOGENESIS_JAW_AND_TOOTH_PROGENITORS | 2.14e-04 | 12 | 48 | 2 | MM3646 | |
| Coexpression | MA_RAT_AGING_DN | 2.16e-04 | 161 | 48 | 4 | M46419 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 2.21e-04 | 162 | 48 | 4 | M45037 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_VASCULAR_ENDOTHELIAL_CELLS | 2.32e-04 | 65 | 48 | 3 | M40266 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 2.35e-04 | 305 | 48 | 5 | M19875 | |
| Coexpression | HORIUCHI_WTAP_TARGETS_UP | 2.49e-04 | 309 | 48 | 5 | M1973 | |
| Coexpression | DESCARTES_FETAL_HEART_SCHWANN_CELLS | 2.54e-04 | 67 | 48 | 3 | M40194 | |
| Coexpression | MA_RAT_AGING_DN | 2.66e-04 | 170 | 48 | 4 | MM16097 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 2.76e-04 | 316 | 48 | 5 | M2293 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 2.77e-04 | 69 | 48 | 3 | M10165 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 2.84e-04 | 318 | 48 | 5 | M41707 | |
| Coexpression | RODWELL_AGING_KIDNEY_UP | 2.94e-04 | 501 | 48 | 6 | M5389 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LIVER_METASTASIS | 2.95e-04 | 14 | 48 | 2 | M48002 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 3.06e-04 | 323 | 48 | 5 | MM1066 | |
| Coexpression | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP | 3.41e-04 | 74 | 48 | 3 | M515 | |
| Coexpression | BRUECKNER_TARGETS_OF_MIRLET7A3_DN | 3.69e-04 | 76 | 48 | 3 | M11825 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 3.71e-04 | 337 | 48 | 5 | MM16606 | |
| Coexpression | ATF2_S_UP.V1_DN | 3.82e-04 | 187 | 48 | 4 | M2681 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | COL23A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL14A1 C1QTNF2 COL11A1 COL16A1 UBTF CALN1 FRMPD2 COL1A2 | 6.27e-11 | 797 | 46 | 15 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | COL4A5 COL4A6 COL5A1 COL6A2 COL14A1 COL11A1 COL16A1 FRMPD2 COL1A2 | 3.47e-10 | 197 | 46 | 9 | gudmap_developingGonad_e16.5_epididymis_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | COL23A1 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL14A1 COL9A2 COL11A1 COL13A1 COL16A1 UBTF FRMPD2 COL1A2 | 6.89e-10 | 790 | 46 | 14 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | COL4A6 COL5A1 COL6A2 COL14A1 COL11A1 COL16A1 COL27A1 FRMPD2 COL1A2 | 1.59e-09 | 234 | 46 | 9 | gudmap_developingGonad_e18.5_epididymis_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | COL23A1 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL14A1 COL11A1 COL16A1 UBTF COL27A1 FRMPD2 COL1A2 | 8.87e-09 | 799 | 46 | 13 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.97e-08 | 229 | 46 | 8 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 6.28e-08 | 97 | 46 | 6 | GSM777043_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | COL4A4 COL4A5 COL6A2 COL14A1 C1QTNF2 COL11A1 UBTF FRMPD2 COL1A2 | 1.46e-07 | 395 | 46 | 9 | gudmap_developingGonad_P2_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.59e-07 | 123 | 46 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k3 | |
| CoexpressionAtlas | BM Top 100 - cervix | 3.09e-07 | 66 | 46 | 5 | BM Top 100 - cervix | |
| CoexpressionAtlas | BM Top 100 - endometrium | 3.09e-07 | 66 | 46 | 5 | BM Top 100 - endometrium | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.97e-07 | 230 | 46 | 7 | gudmap_developingGonad_P2_epididymis_1000_k2 | |
| CoexpressionAtlas | Endoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL2A1 COL4A1 COL23A1 COL4A6 COL5A1 COLEC12 COL6A2 COL9A2 COL11A1 COL13A1 | 6.15e-07 | 615 | 46 | 10 | PCBC_ratio_DE_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.70e-07 | 234 | 46 | 7 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 1.63e-06 | 92 | 46 | 5 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 2.22e-06 | 404 | 46 | 8 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | Mesoderm Day 15-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 15-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 2.46e-06 | 100 | 46 | 5 | PCBC_ratio_MESO-15_from-OSK-L-l-p53KD_vs_MESO-15_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 15-method_episomal_vs_Mesoderm Day 15-method_NA-Confounder_removed-fold2.0_adjp0.05 | 2.46e-06 | 100 | 46 | 5 | PCBC_ratio_MESO-15_from-episomal_vs_MESO-15_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 3.50e-06 | 300 | 46 | 7 | PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL2A1 COL4A1 COL23A1 COL4A5 COL4A6 COL5A1 COLEC12 COL6A2 COL9A2 COL11A1 COL13A1 COL27A1 | 4.33e-06 | 1153 | 46 | 12 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 4.53e-06 | 445 | 46 | 8 | GSM777043_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#5 | 5.11e-06 | 116 | 46 | 5 | ratio_EB_vs_SC_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | COL2A1 MSR1 CKAP5 COL24A1 COL6A2 COL9A2 COL15A1 SCARA3 COL1A2 | 5.14e-06 | 607 | 46 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500 | 5.25e-06 | 206 | 46 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k2 | |
| CoexpressionAtlas | BM Top 100 - myometrium | 1.18e-05 | 65 | 46 | 4 | BM Top 100 - myometrium | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.24e-05 | 139 | 46 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.32e-05 | 141 | 46 | 5 | gudmap_developingGonad_P2_epididymis_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.40e-05 | 371 | 46 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO bone marrow-Confounder_removed-fold2.0_adjp0.05 | 1.42e-05 | 143 | 46 | 5 | PCBC_ratio_ECTO blastocyst_vs_ECTO bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | BM Top 100 - colon cecum | 1.42e-05 | 68 | 46 | 4 | BM Top 100 - colon cecum | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 1.50e-05 | 69 | 46 | 4 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | BM Top 100 - ovary | 1.59e-05 | 70 | 46 | 4 | BM Top 100 - ovary | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL2A1 COL4A1 COL5A1 COLEC12 COL6A2 COL5A3 COL9A2 COL11A1 FRMPD3 COL15A1 COL1A2 | 1.63e-05 | 1094 | 46 | 11 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | BM Top 100 - stomach fundus | 1.68e-05 | 71 | 46 | 4 | BM Top 100 - stomach fundus | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 1.78e-05 | 72 | 46 | 4 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 1.88e-05 | 73 | 46 | 4 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 1.98e-05 | 74 | 46 | 4 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | BM Top 100 - trigeminal ganglia | 2.09e-05 | 75 | 46 | 4 | BM Top 100 - trigeminal ganglia | |
| CoexpressionAtlas | BM Top 100 - urethra | 2.32e-05 | 77 | 46 | 4 | BM Top 100 - urethra | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 2.45e-05 | 78 | 46 | 4 | PCBC_ratio_DE_from-OSKM_vs_DE_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | COL2A1 MSR1 CKAP5 COL24A1 COL6A2 COL9A2 COL15A1 SCARA3 COL1A2 | 2.61e-05 | 744 | 46 | 9 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 2.78e-05 | 413 | 46 | 7 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 3.00e-05 | 280 | 46 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 3.06e-05 | 281 | 46 | 6 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 3.06e-05 | 281 | 46 | 6 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_2500_k-means-cluster#5 | COL4A3 COL4A4 COL14A1 C1QTNF2 COL15A1 COL6A6 COL21A1 COL28A1 | 3.32e-05 | 586 | 46 | 8 | geo_heart_2500_K5 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | MSR1 COL6A2 COL5A3 COL14A1 C1QTNF2 GLDN COL15A1 COL16A1 SCARA3 COL1A2 | 3.78e-05 | 981 | 46 | 10 | PCBC_ctl_BronchSmoothMuscl_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_1000 | MSR1 COL4A4 COL6A2 COL5A3 COL14A1 C1QTNF2 COL15A1 COL16A1 COL1A2 | 3.89e-05 | 783 | 46 | 9 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_500 | 4.49e-05 | 91 | 46 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k5 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.21e-05 | 480 | 46 | 7 | ratio_MESO_vs_SC_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 7.27e-05 | 655 | 46 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 9.51e-05 | 213 | 46 | 5 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | 9.51e-05 | 213 | 46 | 5 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_1000 | 9.72e-05 | 214 | 46 | 5 | gudmap_developingGonad_e16.5_testes_1000_k5 | |
| CoexpressionAtlas | placenta | 1.02e-04 | 349 | 46 | 6 | placenta | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_200 | 1.16e-04 | 116 | 46 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_200_k2 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO fibroblast-Confounder_removed-fold2.0_adjp0.05 | 1.23e-04 | 118 | 46 | 4 | PCBC_ratio_ECTO blastocyst_vs_ECTO fibroblast_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | COL2A1 COL4A1 COL5A1 COL6A2 COL5A3 COL11A1 COL11A2 COL15A1 COL1A2 | 1.72e-04 | 951 | 46 | 9 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | COL2A1 MSR1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL16A1 COL1A2 | 1.95e-04 | 967 | 46 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | COL2A1 COL5A1 COL24A1 COL5A3 COL11A1 COL15A1 COL6A6 COL21A1 COL1A2 | 2.18e-04 | 981 | 46 | 9 | Arv_EB-LF_1000 |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | COL2A1 MSR1 COL4A1 COL4A5 COL4A6 COL5A1 COLEC12 COL9A2 COL13A1 | 2.19e-04 | 982 | 46 | 9 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.24e-04 | 256 | 46 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k4 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL2A1 COL4A5 COL4A6 COLEC12 COL7A1 COL9A2 COL11A1 COL22A1 SCARA3 COL1A2 WDTC1 | 2.30e-04 | 1466 | 46 | 11 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 2.31e-04 | 406 | 46 | 6 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.55e-04 | 589 | 46 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.60e-04 | 591 | 46 | 7 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.63e-04 | 265 | 46 | 5 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | 2.81e-04 | 421 | 46 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 2.90e-04 | 801 | 46 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_100 | 2.99e-04 | 60 | 46 | 3 | gudmap_developingKidney_e15.5_Peripheral blastema_100_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.17e-04 | 276 | 46 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.23e-04 | 814 | 46 | 8 | JC_fibro_2500_K5 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 3.43e-04 | 437 | 46 | 6 | GSM777046_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_500 | 3.61e-04 | 64 | 46 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k2 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 3.62e-04 | 284 | 46 | 5 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.80e-04 | 834 | 46 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.98e-04 | 290 | 46 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.17e-04 | 293 | 46 | 5 | gudmap_developingGonad_e18.5_testes_1000_k4 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 4.24e-04 | 455 | 46 | 6 | GSM777055_500 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 4.70e-04 | 70 | 46 | 3 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.71e-04 | 652 | 46 | 7 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_100 | 4.73e-04 | 15 | 46 | 2 | gudmap_developingGonad_P2_epididymis_100_k1 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 4.82e-04 | 466 | 46 | 6 | GSM777050_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.84e-04 | 655 | 46 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 | |
| CoexpressionAtlas | BM Top 100 - dorsal root ganglia | 4.91e-04 | 71 | 46 | 3 | BM Top 100 - dorsal root ganglia | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.01e-04 | 305 | 46 | 5 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k2 | |
| CoexpressionAtlas | BM Top 100 - stomach cardiac | 5.11e-04 | 72 | 46 | 3 | BM Top 100 - stomach cardiac | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-reprogram_NA_vs_Ectoderm Differentiated Cells-reprogram_OSKM-L-Confounder_removed-fold2.0_adjp0.05 | 5.32e-04 | 73 | 46 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-OSKM-L_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-method_NA_vs_Ectoderm Differentiated Cells-method_mRNA-Confounder_removed-fold2.0_adjp0.05 | 5.32e-04 | 73 | 46 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-mRNA_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.34e-04 | 878 | 46 | 8 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 | |
| CoexpressionAtlas | BM Top 100 - mammary gland | 5.54e-04 | 74 | 46 | 3 | BM Top 100 - mammary gland | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_200 | 5.55e-04 | 175 | 46 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_200 | |
| CoexpressionAtlas | BM Top 100 - vagina | 5.99e-04 | 76 | 46 | 3 | BM Top 100 - vagina | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.14e-04 | 319 | 46 | 5 | gudmap_developingGonad_P2_testes_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 6.20e-04 | 489 | 46 | 6 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#5_top-relative-expression-ranked_500 | 6.22e-04 | 77 | 46 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500_k5 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-reprogram_NA_vs_Ectoderm Differentiated Cells-reprogram_OSKM - NLT-Confounder_removed-fold2.0_adjp0.05 | 6.46e-04 | 78 | 46 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-OSKM - NLT_cfr-2X-p05 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K0 | COL5A1 COL6A2 COL14A1 GLDN COL15A1 COL16A1 COL6A6 SCARA3 COL1A2 | 6.67e-04 | 1143 | 46 | 9 | gudmap_RNAseq_e15.5_Podocytes_2500_K0 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500 | 6.68e-04 | 496 | 46 | 6 | Arv_EB-LF_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.70e-04 | 184 | 46 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL4A1 COL4A5 COL5A1 COL6A2 COL5A3 COL14A1 C1QTNF2 COL11A1 COL11A2 COL15A1 COL16A1 COL1A2 | 2.63e-20 | 198 | 48 | 13 | b086af292a508a156266c2d899ba1caf820bf61c |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL5A1 COLEC12 COL6A2 COL14A1 C1QTNF2 COL11A1 COL22A1 COL11A2 COL13A1 COL15A1 COL16A1 COL1A2 | 2.63e-20 | 198 | 48 | 13 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | COL2A1 COL5A1 COL24A1 COL6A2 COL9A2 COL11A1 COL11A2 COL15A1 COL16A1 SCARA3 COL27A1 COL1A2 | 1.21e-18 | 188 | 48 | 12 | 7b1e3f8a941eaa68e89c562129a92314642eec66 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL4A5 COL5A1 COL6A2 COL5A3 COL14A1 C1QTNF2 COL11A1 COL11A2 COL15A1 COL16A1 COL1A2 | 2.28e-18 | 198 | 48 | 12 | 1b90d632e59c3c47b936e829cceeb0334f05f34f |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | COL4A1 COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 SCARA3 COL1A2 | 2.43e-18 | 199 | 48 | 12 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL4A1 COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 SCARA3 COL1A2 | 2.58e-18 | 200 | 48 | 12 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL4A1 COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 SCARA3 COL1A2 | 2.58e-18 | 200 | 48 | 12 | 50ca6550998e461ef26dd670351060bd940765a8 |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | COL4A5 COL4A6 COL5A1 COLEC12 COL6A2 COL6A5 C1QTNF2 COL13A1 COL15A1 COL21A1 COL1A2 | 1.06e-16 | 189 | 48 | 11 | 4f9608b84d135268a17455661870c46ae8554a24 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL2A1 COL5A1 COL6A2 COL14A1 C1QTNF2 COL11A1 FRMPD3 COL16A1 COL6A6 COL27A1 COL1A2 | 1.06e-16 | 189 | 48 | 11 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL2A1 COL5A1 COL6A2 COL14A1 C1QTNF2 COL11A1 FRMPD3 COL16A1 COL6A6 COL27A1 COL1A2 | 1.06e-16 | 189 | 48 | 11 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL2A1 COL5A1 COL6A2 COL14A1 C1QTNF2 COL11A1 FRMPD3 COL16A1 COL6A6 COL27A1 COL1A2 | 1.19e-16 | 191 | 48 | 11 | 5271198116343c07202649889057e5774d7fdde3 |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL5A1 COL6A2 COL5A3 COL14A1 COL7A1 C1QTNF2 COL11A1 COL16A1 COL6A6 SCARA3 COL1A2 | 1.19e-16 | 191 | 48 | 11 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 SCARA3 COL1A2 | 1.26e-16 | 192 | 48 | 11 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL5A1 COLEC12 COL6A2 COL9A2 COL11A1 COL11A2 COL16A1 SCARA3 COL27A1 COL1A2 | 1.78e-16 | 198 | 48 | 11 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL2A1 COL5A1 COLEC12 COL6A2 COL9A2 COL11A1 COL11A2 COL16A1 SCARA3 COL27A1 COL1A2 | 1.78e-16 | 198 | 48 | 11 | 1beed34f469aad07e8f674f0b668d6e1e916403c |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL2A1 COL5A1 COLEC12 COL6A2 COL9A2 COL11A1 COL11A2 COL16A1 SCARA3 COL27A1 COL1A2 | 1.78e-16 | 198 | 48 | 11 | 985022c1722ab7b67675ebe814022a439e715b5e |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 SCARA3 COL1A2 | 1.88e-16 | 199 | 48 | 11 | ba586690f88fd051f449753bfe7603a2cb431782 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 SCARA3 COL1A2 | 1.88e-16 | 199 | 48 | 11 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 C1QTNF2 COL13A1 COL16A1 COL6A6 COL21A1 COL1A2 | 1.88e-16 | 199 | 48 | 11 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | COL4A1 COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 COL1A2 | 1.88e-16 | 199 | 48 | 11 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | COL4A1 COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL16A1 COL6A6 COL21A1 SCARA3 COL1A2 | 1.88e-16 | 199 | 48 | 11 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | COL4A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 SCARA3 COL1A2 | 1.88e-16 | 199 | 48 | 11 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL4A1 COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 COL1A2 | 1.99e-16 | 200 | 48 | 11 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 C1QTNF2 COL16A1 COL6A6 COL21A1 SCARA3 COL1A2 | 1.99e-16 | 200 | 48 | 11 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | COL4A1 COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 COL1A2 | 1.99e-16 | 200 | 48 | 11 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL5A3 COL14A1 COL15A1 COL1A2 | 4.68e-15 | 180 | 48 | 10 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL6A2 COL5A3 COL7A1 COL11A1 COL13A1 COL15A1 COL16A1 COL27A1 COL1A2 | 5.53e-15 | 183 | 48 | 10 | 803376f5260de83c48d4f7301278d078a32b3e6e |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL6A2 COL5A3 COL7A1 COL11A1 COL13A1 COL15A1 COL16A1 COL27A1 COL1A2 | 5.53e-15 | 183 | 48 | 10 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL6A2 COL5A3 COL7A1 COL11A1 COL13A1 COL15A1 COL16A1 COL27A1 COL1A2 | 5.53e-15 | 183 | 48 | 10 | cc7f5a17b40e8d901885174922e5fa8877643071 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL6A2 COL5A3 COL14A1 C1QTNF2 COL11A1 COL15A1 COL16A1 COL27A1 COL1A2 | 6.17e-15 | 185 | 48 | 10 | 87c416d14ca6255bee39b16e7571553e36ee3069 |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL5A1 COLEC12 COL6A2 COL5A3 COL14A1 C1QTNF2 COL11A1 COL15A1 COL16A1 COL1A2 | 6.17e-15 | 185 | 48 | 10 | 785c55d39909fac74415f24427979691e7e694e6 |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL5A1 COLEC12 COL6A2 COL5A3 COL14A1 C1QTNF2 COL11A1 COL15A1 COL16A1 COL1A2 | 6.17e-15 | 185 | 48 | 10 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL5A1 COLEC12 COL6A2 COL5A3 COL14A1 C1QTNF2 COL11A1 COL15A1 COL16A1 COL1A2 | 6.52e-15 | 186 | 48 | 10 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL4A3 COL4A4 COL4A5 COL5A1 COL24A1 COL6A2 COL14A1 COL15A1 SCARA3 COL1A2 | 6.88e-15 | 187 | 48 | 10 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL5A1 COL6A2 COL5A3 COL14A1 C1QTNF2 COL11A1 COL16A1 COL6A6 SCARA3 COL1A2 | 8.52e-15 | 191 | 48 | 10 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A1 COL4A4 COL5A1 COLEC12 COL6A2 COL5A3 C1QTNF2 COL15A1 COL16A1 COL1A2 | 8.52e-15 | 191 | 48 | 10 | b7a57691a4742070cee640e285c1f4d0da95baf1 |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A3 COL4A4 COL5A1 COLEC12 COL6A2 COL5A3 C1QTNF2 COL15A1 COL16A1 COL1A2 | 8.98e-15 | 192 | 48 | 10 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A5 COL5A1 COL6A2 COL5A3 COL14A1 COL15A1 COL16A1 COL6A6 SCARA3 COL1A2 | 8.98e-15 | 192 | 48 | 10 | beac6b3c191b11add8e39e8d04562b478ea8929e |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL4A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 SCARA3 COL1A2 | 8.98e-15 | 192 | 48 | 10 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A3 COL4A4 COL5A1 COLEC12 COL6A2 COL5A3 C1QTNF2 COL15A1 COL16A1 COL1A2 | 8.98e-15 | 192 | 48 | 10 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 COL1A2 | 8.98e-15 | 192 | 48 | 10 | deeecd26972241846b4cb998edf0c7a87ff0c4df |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 COL1A2 | 9.47e-15 | 193 | 48 | 10 | fb28717fadd06c3840636d25409ce80c9254bd34 |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL5A1 COLEC12 COL6A2 COL5A3 COL14A1 C1QTNF2 COL15A1 COL6A6 SCARA3 COL1A2 | 9.47e-15 | 193 | 48 | 10 | 160691b671710be10220803d788c2c961c236af1 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 COL1A2 | 9.98e-15 | 194 | 48 | 10 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A1 COL23A1 COL4A5 COL5A1 COL6A2 COL5A3 COL14A1 C1QTNF2 COL15A1 COL1A2 | 9.98e-15 | 194 | 48 | 10 | 3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | MSR1 COL5A1 COLEC12 COL6A2 COL14A1 COL13A1 COL16A1 COL6A6 COL21A1 COL1A2 | 9.98e-15 | 194 | 48 | 10 | 8c37bedb23285735ff3828db3889897fada8c95d |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 SCARA3 COL1A2 | 9.98e-15 | 194 | 48 | 10 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL4A1 COL23A1 COL4A5 COL5A1 COL6A2 COL5A3 COL14A1 C1QTNF2 COL15A1 COL1A2 | 9.98e-15 | 194 | 48 | 10 | ff19fb5bc7feae3e774ef4ab720beb9dec219f45 |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | COL4A6 COL5A1 COLEC12 COL6A2 COL14A1 C1QTNF2 COL13A1 COL15A1 COL21A1 COL1A2 | 1.05e-14 | 195 | 48 | 10 | f86737bff21d81673238813df61a15cfe88d0b15 |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | COL2A1 COLEC12 COL6A2 COL9A2 COL11A1 COL15A1 COL16A1 SCARA3 COL27A1 COL1A2 | 1.11e-14 | 196 | 48 | 10 | ddc168849e0e97005a111be004463bb72d433853 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | COL4A1 COLEC12 COL6A2 COL14A1 COL6A5 COL16A1 COL6A6 COL21A1 SCARA3 COL1A2 | 1.16e-14 | 197 | 48 | 10 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COL2A1 COL5A1 COL6A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 SCARA3 COL1A2 | 1.23e-14 | 198 | 48 | 10 | 1f956e369e00d37835095a001db4b62a79014532 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COL2A1 COL5A1 COL6A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 SCARA3 COL1A2 | 1.23e-14 | 198 | 48 | 10 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A1 COL4A5 COL5A1 COLEC12 COL6A2 COL5A3 COL14A1 COL15A1 SCARA3 COL1A2 | 1.23e-14 | 198 | 48 | 10 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 SCARA3 COL1A2 | 1.29e-14 | 199 | 48 | 10 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | COL5A1 COL6A2 COL5A3 COL14A1 COL6A5 C1QTNF2 COL13A1 COL16A1 COL6A6 COL1A2 | 1.29e-14 | 199 | 48 | 10 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | COL4A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 SCARA3 COL1A2 | 1.29e-14 | 199 | 48 | 10 | 211c3a08f2d484ab7a3368006767289088f0d957 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COLEC12 COL6A2 COL5A3 COL14A1 C1QTNF2 COL16A1 COL6A6 COL21A1 COL1A2 | 1.29e-14 | 199 | 48 | 10 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | COL4A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 SCARA3 COL1A2 | 1.29e-14 | 199 | 48 | 10 | 1a0add79f4e34078b3475eb11c85a4234bda197c |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 COL1A2 | 1.36e-14 | 200 | 48 | 10 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COLEC12 COL6A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 SCARA3 COL1A2 | 1.36e-14 | 200 | 48 | 10 | 780d47f8eff630020dfae32218de495a7e9dbad6 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COL5A1 COLEC12 COL24A1 COL6A2 COL14A1 COL11A1 COL16A1 COL6A6 SCARA3 COL1A2 | 1.36e-14 | 200 | 48 | 10 | a4ec0e80f5422b91b85264a9bb74568dd577e285 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COLEC12 COL6A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 SCARA3 COL1A2 | 1.36e-14 | 200 | 48 | 10 | 28dd127787a57276253548d1f030814b1af64481 |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COL2A1 COL4A1 COL5A1 COLEC12 COL6A2 COL11A1 COL11A2 COL15A1 COL16A1 COL1A2 | 1.36e-14 | 200 | 48 | 10 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 COL1A2 | 1.36e-14 | 200 | 48 | 10 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 COL1A2 | 1.36e-14 | 200 | 48 | 10 | bd8cf33502adea320e91ca2af14e1911d88ad374 |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | COL23A1 COL4A5 COL4A6 COL5A1 COL6A2 COL22A1 COL13A1 COL15A1 COL1A2 | 7.18e-14 | 153 | 48 | 9 | e9c6fb5c41adb6595c66c3a917fe455348279e54 |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | COL23A1 COL4A5 COL4A6 COL5A1 COL6A2 COL22A1 COL13A1 COL15A1 COL1A2 | 7.18e-14 | 153 | 48 | 9 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | COL23A1 COL4A5 COL4A6 COL5A1 COL6A2 COL22A1 COL13A1 COL15A1 COL1A2 | 7.18e-14 | 153 | 48 | 9 | 2513edfae62a44e51d3556675a096723194c966c |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | COL23A1 COL4A4 COL5A1 COL6A2 COL5A3 COL14A1 COL15A1 COL16A1 COL1A2 | 1.02e-13 | 159 | 48 | 9 | e812cbde59188924c6277c3feadf1a9592fa62a4 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | COL23A1 COL4A4 COL5A1 COL6A2 COL5A3 COL14A1 COL15A1 COL16A1 COL1A2 | 1.02e-13 | 159 | 48 | 9 | 2607b562903228274fbd96168ba826782fab0b53 |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | COL4A5 COL4A6 COLEC12 COL6A2 COL7A1 COL22A1 COL13A1 COL15A1 COL1A2 | 1.02e-13 | 159 | 48 | 9 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL6A2 COL5A3 COL7A1 COL11A1 COL13A1 COL15A1 COL16A1 COL1A2 | 3.15e-13 | 180 | 48 | 9 | 935c091bbcd6d10b81dc4731779e5bd98205c99f |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL4A1 COL5A1 COLEC12 COL24A1 COL6A2 COL6A5 COL13A1 COL15A1 COL1A2 | 3.15e-13 | 180 | 48 | 9 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL6A2 COL5A3 COL7A1 COL11A1 COL13A1 COL15A1 COL16A1 COL1A2 | 3.15e-13 | 180 | 48 | 9 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | COL4A1 COL23A1 COL5A1 COL24A1 COL6A2 COL7A1 COL22A1 SCARA3 COL27A1 | 3.48e-13 | 182 | 48 | 9 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | COL5A1 COLEC12 COL6A2 COL5A3 COL14A1 C1QTNF2 COL15A1 COL16A1 COL1A2 | 3.84e-13 | 184 | 48 | 9 | 01257e5c12e38b849fd3d9496c43ded666249ba5 |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL15A1 COL16A1 COL27A1 COL1A2 | 3.84e-13 | 184 | 48 | 9 | 0b336489c10e8c3c957795dd845454f03404382b |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | COL23A1 COL4A4 COL5A1 COL6A2 COL5A3 COL14A1 COL15A1 COL16A1 COL1A2 | 3.84e-13 | 184 | 48 | 9 | c5436a8e45f471b8d1301abbe9c7879204537f52 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | COL2A1 COL24A1 COL9A2 COL11A1 COL11A2 COL15A1 COL16A1 SCARA3 COL27A1 | 4.03e-13 | 185 | 48 | 9 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL6A2 COL14A1 COL6A5 COL13A1 COL15A1 COL16A1 COL6A6 COL1A2 | 4.24e-13 | 186 | 48 | 9 | 5473283fb95cee556b1f6934cf72169b676b5bcc |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL16A1 COL1A2 | 4.67e-13 | 188 | 48 | 9 | b382d18fb09fb2869f3c151efa71540a7f5ed229 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 COL1A2 | 4.90e-13 | 189 | 48 | 9 | a153b83314cf52808f685296cff8c95af3f4983d |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL5A1 COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL1A2 | 4.90e-13 | 189 | 48 | 9 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 C1QTNF2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 SCARA3 COL1A2 | 5.14e-13 | 190 | 48 | 9 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 COL1A2 | 5.39e-13 | 191 | 48 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL5A1 COL6A2 COL5A3 COL14A1 C1QTNF2 COL11A1 COL16A1 SCARA3 COL1A2 | 5.39e-13 | 191 | 48 | 9 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | COL4A4 COL5A1 COLEC12 COL14A1 COL15A1 COL16A1 COL21A1 COL27A1 COL1A2 | 5.65e-13 | 192 | 48 | 9 | 9093a9e94a25682d109a7f6edc256a25a61103a0 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 COL1A2 | 5.65e-13 | 192 | 48 | 9 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL5A1 COLEC12 COL6A2 COL5A3 COL14A1 COL15A1 COL16A1 SCARA3 COL1A2 | 5.65e-13 | 192 | 48 | 9 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL5A1 COLEC12 COL6A2 COL5A3 COL14A1 C1QTNF2 COL15A1 COL16A1 COL1A2 | 5.65e-13 | 192 | 48 | 9 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | COL4A4 COL5A1 COLEC12 COL14A1 COL15A1 COL16A1 COL21A1 COL27A1 COL1A2 | 5.65e-13 | 192 | 48 | 9 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | COL4A1 COL4A3 COL4A4 COL5A1 COL24A1 COL6A2 COL5A3 COL15A1 COL1A2 | 5.65e-13 | 192 | 48 | 9 | 356160b113c3305a61ceeaff33ce3c9da0be2878 |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL5A1 COLEC12 COL6A2 COL5A3 COL14A1 COL15A1 COL16A1 SCARA3 COL1A2 | 5.65e-13 | 192 | 48 | 9 | eeab1cef7c36ae824381952c5b2c982368c379fd |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL5A1 COLEC12 COL6A2 COL5A3 COL14A1 C1QTNF2 COL15A1 COL16A1 COL1A2 | 5.65e-13 | 192 | 48 | 9 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL4A1 COLEC12 COL6A2 COL14A1 COL6A5 COL16A1 COL6A6 SCARA3 COL1A2 | 5.65e-13 | 192 | 48 | 9 | df1545670370fb1010c567cd059c2783eab315f7 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COLEC12 COL6A2 COL14A1 COL6A5 COL13A1 COL16A1 COL6A6 COL21A1 COL1A2 | 5.65e-13 | 192 | 48 | 9 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL4A1 COLEC12 COL6A2 COL14A1 COL6A5 COL16A1 COL6A6 SCARA3 COL1A2 | 5.65e-13 | 192 | 48 | 9 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL5A1 COLEC12 COL6A2 COL5A3 COL14A1 C1QTNF2 COL15A1 COL16A1 COL1A2 | 5.65e-13 | 192 | 48 | 9 | ac1477433704573f95111eee6263b93668d2845e |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL5A1 COLEC12 COL6A2 COL5A3 COL14A1 COL7A1 C1QTNF2 COL16A1 COL1A2 | 5.65e-13 | 192 | 48 | 9 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 |
| Computational | Adhesion molecules. | 9.19e-10 | 141 | 26 | 8 | MODULE_122 | |
| Computational | ECM and collagens. | 7.52e-07 | 225 | 26 | 7 | MODULE_47 | |
| Computational | Neighborhood of CDH11 | 2.79e-05 | 25 | 26 | 3 | GNF2_CDH11 | |
| Computational | Spinal cord (neuro-development) genes. | 1.76e-04 | 360 | 26 | 6 | MODULE_12 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.28e-04 | 50 | 26 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.28e-04 | 50 | 26 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.28e-04 | 50 | 26 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Ovary genes. | 1.66e-03 | 368 | 26 | 5 | MODULE_1 | |
| Drug | GK-101 | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 1.23e-46 | 36 | 47 | 20 | CID000161853 |
| Drug | Madecassol | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 9.31e-44 | 46 | 47 | 20 | CID000108062 |
| Drug | AC1LAKND | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 3.57e-43 | 62 | 47 | 21 | CID000470146 |
| Drug | d-indobufen | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 7.79e-43 | 50 | 47 | 20 | CID000044562 |
| Drug | ridogrel | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 2.08e-42 | 52 | 47 | 20 | CID005362391 |
| Drug | NSC49633 | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 3.33e-42 | 53 | 47 | 20 | CID000023340 |
| Drug | BAPN | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 1.05e-41 | 71 | 47 | 21 | CID000001647 |
| Drug | halofuginone lactate | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 8.22e-40 | 85 | 47 | 21 | CID000062891 |
| Drug | malotilate | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 3.64e-39 | 71 | 47 | 20 | CID000004006 |
| Drug | 4-hydroxyproline | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 4.15e-39 | 91 | 47 | 21 | CID000000825 |
| Drug | AC1NMZ1B | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 1.29e-38 | 75 | 47 | 20 | CID005034185 |
| Drug | strontium ranelate | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 2.36e-38 | 77 | 47 | 20 | CID006918182 |
| Drug | ticlopidine | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 7.56e-38 | 103 | 47 | 21 | CID000005472 |
| Drug | hydroxylysine | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 2.81e-37 | 109 | 47 | 21 | CID000001029 |
| Drug | PCR 4099 | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 WDTC1 | 4.42e-37 | 139 | 47 | 22 | CID000002806 |
| Drug | Tranilast sodium | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 9.64e-37 | 115 | 47 | 21 | CID000005527 |
| Drug | DMSe | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL5A3 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 2.23e-35 | 132 | 47 | 21 | CID000020796 |
| Drug | pirfenidone | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 6.09e-35 | 138 | 47 | 21 | CID000040632 |
| Drug | AC1L1C2F | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 6.78e-35 | 110 | 47 | 20 | CID000001711 |
| Drug | DL-penicillamine | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 7.16e-35 | 139 | 47 | 21 | CID000004727 |
| Drug | PPACK | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 1.22e-34 | 113 | 47 | 20 | CID003036757 |
| Drug | AC1L9732 | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 1.48e-34 | 114 | 47 | 20 | CID000439300 |
| Drug | Selara | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 1.09e-33 | 125 | 47 | 20 | CID000150310 |
| Drug | khellin | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 7.32e-33 | 171 | 47 | 21 | CID000003828 |
| Drug | AC1L1DD6 | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 2.01e-32 | 179 | 47 | 21 | CID000002299 |
| Drug | candesartan cilexetil | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 2.61e-32 | 145 | 47 | 20 | CID000002540 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 2.73e-31 | 162 | 47 | 20 | CID000072363 |
| Drug | hyaluronan | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 SCARA3 COL27A1 COL1A2 | 1.12e-30 | 263 | 47 | 22 | CID000024759 |
| Drug | AC1Q6PCP | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 4.86e-30 | 230 | 47 | 21 | CID000005267 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 6.92e-30 | 189 | 47 | 20 | CID000001413 |
| Drug | foscarnet | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 7.73e-30 | 190 | 47 | 20 | CID000003414 |
| Drug | prostacyclin sodium salt | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 UBTF COL27A1 COL1A2 | 2.96e-29 | 250 | 47 | 21 | CID000000159 |
| Drug | silibinin | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 4.98e-28 | 285 | 47 | 21 | CID000005213 |
| Drug | AC1L18QD | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 8.26e-27 | 325 | 47 | 21 | CID000000213 |
| Drug | losartan | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 2.04e-25 | 378 | 47 | 21 | CID000003961 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 2.35e-25 | 314 | 47 | 20 | CID000447989 |
| Drug | colchine | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 2.70e-25 | 383 | 47 | 21 | CID000002833 |
| Drug | AC1L1KMJ | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COLEC12 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 6.29e-25 | 476 | 47 | 22 | CID000030956 |
| Drug | chondroitin sulfate | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 1.32e-24 | 413 | 47 | 21 | CID000024766 |
| Drug | Y-27632 | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 2.49e-22 | 444 | 47 | 20 | CID000005711 |
| Drug | aspirin | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 8.63e-22 | 563 | 47 | 21 | CID000002244 |
| Drug | L-3,4-dehydroproline | COL2A1 COL23A1 COL5A1 COL6A2 COL7A1 COL11A1 COL22A1 COL13A1 COL16A1 COL19A1 COL21A1 COL1A2 | 2.18e-20 | 73 | 47 | 12 | CID000094284 |
| Drug | LMWH | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 C1QTNF2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL21A1 COL27A1 COL1A2 | 2.53e-20 | 663 | 47 | 21 | CID000000772 |
| Drug | LS-63783 | COL2A1 COL4A1 COL23A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL14A1 COL7A1 COL9A2 COL11A1 COL22A1 COL11A2 COL13A1 COL16A1 COL19A1 COL21A1 COL27A1 COL1A2 | 1.31e-18 | 804 | 47 | 21 | CID000000231 |
| Drug | NC-4 | COL2A1 COL5A1 COL9A2 COL11A1 COL11A2 COL13A1 COL21A1 COL27A1 | 2.95e-14 | 44 | 47 | 8 | CID006420119 |
| Drug | isodesmosine | 4.11e-13 | 33 | 47 | 7 | CID000013811 | |
| Drug | 351A | 2.11e-12 | 20 | 47 | 6 | CID000122144 | |
| Drug | 1zd2 | 4.28e-12 | 45 | 47 | 7 | CID004149241 | |
| Drug | desmosine | 1.44e-11 | 53 | 47 | 7 | CID000025435 | |
| Drug | dermatan sulfate | COL2A1 COL4A3 COL4A5 COL5A1 COL6A2 COL9A2 COL11A1 COL11A2 COL21A1 COL27A1 | 2.19e-11 | 220 | 47 | 10 | CID000032756 |
| Drug | pyridinoline | 2.62e-11 | 99 | 47 | 8 | CID000105068 | |
| Drug | 4-aminoazobenzene | 7.11e-11 | 66 | 47 | 7 | CID000006051 | |
| Drug | BPAT-143 | 2.38e-10 | 6 | 47 | 4 | CID000146249 | |
| Drug | PD123177 | 3.20e-10 | 43 | 47 | 6 | CID000114899 | |
| Drug | 2,3-pentanedione | 8.29e-09 | 129 | 47 | 7 | ctd:C013186 | |
| Drug | Sirius red | 9.33e-09 | 35 | 47 | 5 | CID005486818 | |
| Drug | AC1MRIIV | 1.64e-08 | 39 | 47 | 5 | CID003518584 | |
| Drug | AC1L9HPX | 3.47e-08 | 92 | 47 | 6 | CID000445279 | |
| Drug | 1h00 | 1.06e-07 | 56 | 47 | 5 | CID000445950 | |
| Drug | trapidil | 1.16e-07 | 57 | 47 | 5 | CID000005531 | |
| Drug | AC1Q641C | 1.78e-07 | 62 | 47 | 5 | CID000005005 | |
| Drug | pyrachlostrobin | MSR1 COL4A1 COL4A5 COL4A6 COL5A1 COLEC12 COL5A3 COL11A1 COL22A1 COL16A1 COL19A1 | 5.90e-07 | 811 | 47 | 11 | ctd:C513428 |
| Drug | homocystine | 7.30e-07 | 82 | 47 | 5 | CID000010010 | |
| Drug | sodium chloride | COL4A3 COL4A5 COL5A1 COLEC12 COL6A2 COL7A1 COL9A2 COL11A1 COL13A1 COL21A1 COL1A2 | 1.11e-06 | 865 | 47 | 11 | CID000000206 |
| Drug | fluoride | 1.55e-06 | 278 | 47 | 7 | CID000014917 | |
| Drug | angiotensin | 1.71e-06 | 282 | 47 | 7 | CID003083715 | |
| Drug | isocycloheximide | COL2A1 COL5A1 COL5A3 COL7A1 COL11A1 COL11A2 ADRA2B COL21A1 UBTF COL27A1 COL1A2 | 1.73e-06 | 905 | 47 | 11 | CID000002900 |
| Drug | 17-isoprogesterone | COL2A1 COL4A3 COL4A5 COL5A1 COL7A1 COL11A1 COL11A2 COL16A1 COL21A1 UBTF COL27A1 COL1A2 | 3.14e-06 | 1170 | 47 | 12 | CID000004920 |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.29e-06 | 199 | 47 | 6 | 3606_UP | |
| Drug | Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 3.39e-06 | 200 | 47 | 6 | 5626_UP | |
| Drug | 2-(4-((4-(6-methoxy-3-pyridinyl)-5-(4-(trifluoromethoxy)phenyl)-2-thiazolyl)methoxy)-2-methylphenoxy)acetic acid | 4.01e-06 | 52 | 47 | 4 | ctd:C573693 | |
| Drug | mitomycin C | 9.87e-06 | 241 | 47 | 6 | CID000005746 | |
| Drug | CP-331 | 1.25e-05 | 3 | 47 | 2 | CID000130967 | |
| Drug | calcium phosphate | 1.38e-05 | 149 | 47 | 5 | CID000024441 | |
| Drug | calcium pyrophosphate | 1.65e-05 | 74 | 47 | 4 | CID000024632 | |
| Drug | arabinosyladenine | COL2A1 COL4A5 COL5A1 COL11A2 ADRA2B COL21A1 UBTF COL27A1 COL1A2 | 2.19e-05 | 762 | 47 | 9 | CID000000191 |
| Drug | diphenylamine-2-carboxylate | 2.19e-05 | 164 | 47 | 5 | CID000004386 | |
| Drug | NSC-333492 | 2.50e-05 | 4 | 47 | 2 | CID000333256 | |
| Drug | Collagenase | 2.50e-05 | 4 | 47 | 2 | DB00048 | |
| Drug | Brn 2557402 | 2.50e-05 | 4 | 47 | 2 | CID000042742 | |
| Drug | ethylnylestradiol | COL2A1 MSR1 COL4A3 COL4A5 COL5A1 COL7A1 COL11A2 COL21A1 UBTF COL27A1 COL1A2 | 3.68e-05 | 1251 | 47 | 11 | CID000003285 |
| Drug | dimethylmalonimidate | 4.15e-05 | 5 | 47 | 2 | CID000189133 | |
| Drug | Cyclo-rgdphg | 4.15e-05 | 5 | 47 | 2 | CID006449872 | |
| Drug | D3273 | 4.24e-05 | 94 | 47 | 4 | CID005464587 | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; HL60; HT_HG-U133A | 5.01e-05 | 195 | 47 | 5 | 2538_UP | |
| Drug | Thiorphan [76721-89-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 5.26e-05 | 197 | 47 | 5 | 2752_UP | |
| Drug | Sialic acids | 5.67e-05 | 329 | 47 | 6 | CID000349960 | |
| Drug | 4-fluoranylproline | 6.22e-05 | 6 | 47 | 2 | CID000450594 | |
| Drug | Diphosphonates | 6.22e-05 | 6 | 47 | 2 | ctd:D004164 | |
| Drug | 2-(ethylsulfonyl)ethanol | 7.12e-05 | 210 | 47 | 5 | CID000010549 | |
| Drug | AC1L1HWN | 8.70e-05 | 7 | 47 | 2 | CID000004323 | |
| Drug | rhamnose | 8.76e-05 | 356 | 47 | 6 | CID000000840 | |
| Drug | balofloxacin | 8.94e-05 | 42 | 47 | 3 | CID000065958 | |
| Drug | NSC27366 | 1.16e-04 | 8 | 47 | 2 | CID000231329 | |
| Drug | Sc 40827 | 1.16e-04 | 8 | 47 | 2 | CID000127918 | |
| Drug | Rgd Peptide | 1.31e-04 | 239 | 47 | 5 | CID000104802 | |
| Drug | p-menthane | 1.49e-04 | 9 | 47 | 2 | CID000007459 | |
| Drug | haloperidol | 1.52e-04 | 394 | 47 | 6 | CID000003559 | |
| Drug | aldosterone | 1.59e-04 | 397 | 47 | 6 | CID000005839 | |
| Drug | Simvastatin | 1.76e-04 | 581 | 47 | 7 | ctd:D019821 | |
| Disease | collagen disease (implicated_via_orthology) | 6.47e-12 | 12 | 47 | 5 | DOID:854 (implicated_via_orthology) | |
| Disease | Stickler syndrome | 2.82e-11 | 5 | 47 | 4 | cv:C0265253 | |
| Disease | myopathy (implicated_via_orthology) | 1.37e-10 | 48 | 47 | 6 | DOID:423 (implicated_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.54e-10 | 53 | 47 | 6 | C4707243 | |
| Disease | Hereditary hearing loss and deafness | 3.35e-09 | 146 | 47 | 7 | cv:C0236038 | |
| Disease | skin disease (implicated_via_orthology) | 3.79e-09 | 3 | 47 | 3 | DOID:37 (implicated_via_orthology) | |
| Disease | Alport syndrome | 3.79e-09 | 3 | 47 | 3 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 3.79e-09 | 3 | 47 | 3 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 1.51e-08 | 4 | 47 | 3 | C0241908 | |
| Disease | Alport Syndrome | 1.51e-08 | 4 | 47 | 3 | C1567741 | |
| Disease | Stickler syndrome, type 1 | 3.78e-08 | 5 | 47 | 3 | C2020284 | |
| Disease | Alport Syndrome, X-Linked | 3.78e-08 | 5 | 47 | 3 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 3.78e-08 | 5 | 47 | 3 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 3.78e-08 | 5 | 47 | 3 | C1567744 | |
| Disease | Early Pregnancy Loss | 8.50e-07 | 109 | 47 | 5 | C3830362 | |
| Disease | Miscarriage | 8.50e-07 | 109 | 47 | 5 | C4552766 | |
| Disease | Spontaneous abortion | 8.50e-07 | 109 | 47 | 5 | C0000786 | |
| Disease | Abortion, Tubal | 8.50e-07 | 109 | 47 | 5 | C0000822 | |
| Disease | Leiomyomatosis, esophageal and vulval, with nephropathy | 2.48e-06 | 2 | 47 | 2 | C1839884 | |
| Disease | benign familial hematuria (is_implicated_in) | 2.48e-06 | 2 | 47 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | Fibrochondrogenesis | 2.48e-06 | 2 | 47 | 2 | C0265282 | |
| Disease | Alport syndrome, recessive type | 2.48e-06 | 2 | 47 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 2.48e-06 | 2 | 47 | 2 | C2931253 | |
| Disease | Megaepiphyseal dwarfism | 2.48e-06 | 2 | 47 | 2 | C1855310 | |
| Disease | Otospondylomegaepiphyseal dysplasia | 2.48e-06 | 2 | 47 | 2 | C4520892 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 2.48e-06 | 2 | 47 | 2 | C4746745 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 2.48e-06 | 2 | 47 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 2.48e-06 | 2 | 47 | 2 | C0403440 | |
| Disease | Benign familial hematuria | 2.48e-06 | 2 | 47 | 2 | cv:C0241908 | |
| Disease | Stickler syndrome (implicated_via_orthology) | 2.48e-06 | 2 | 47 | 2 | DOID:0080046 (implicated_via_orthology) | |
| Disease | Leiomyoma, Epithelioid | 2.48e-06 | 2 | 47 | 2 | C0086533 | |
| Disease | Stickler syndrome, type 3 | 2.48e-06 | 2 | 47 | 2 | C1861481 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.60e-06 | 19 | 47 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | Multiple Epiphyseal Dysplasia | 4.24e-06 | 20 | 47 | 3 | C0026760 | |
| Disease | Renal glomerular disease | 6.56e-06 | 23 | 47 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 6.56e-06 | 23 | 47 | 3 | C4521256 | |
| Disease | Disproportionate short stature | 7.02e-06 | 77 | 47 | 4 | C0878659 | |
| Disease | Alport syndrome (is_implicated_in) | 7.44e-06 | 3 | 47 | 2 | DOID:10983 (is_implicated_in) | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 7.44e-06 | 3 | 47 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Cleft Palate | 8.59e-06 | 81 | 47 | 4 | C0008925 | |
| Disease | Stickler syndrome (is_implicated_in) | 1.49e-05 | 4 | 47 | 2 | DOID:0080046 (is_implicated_in) | |
| Disease | Disorder of eye | 2.19e-05 | 212 | 47 | 5 | C0015397 | |
| Disease | Cartilage Diseases | 3.71e-05 | 6 | 47 | 2 | C0007302 | |
| Disease | hypertensive nephropathy | 3.71e-05 | 6 | 47 | 2 | C0848548 | |
| Disease | Chondromalacia | 3.71e-05 | 6 | 47 | 2 | C0085700 | |
| Disease | Intervertebral disc disorder | 3.71e-05 | 6 | 47 | 2 | C0158252 | |
| Disease | lifestyle measurement, maximum cigarettes per day measurement | 4.32e-05 | 122 | 47 | 4 | EFO_0009264, EFO_0010724 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 8.88e-05 | 9 | 47 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | Hematuria | 8.88e-05 | 9 | 47 | 2 | C0018965 | |
| Disease | Sensory hearing loss | 1.35e-04 | 11 | 47 | 2 | C1691779 | |
| Disease | intraocular pressure measurement | 1.51e-04 | 509 | 47 | 6 | EFO_0004695 | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.62e-04 | 12 | 47 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | cleft palate (is_implicated_in) | 1.62e-04 | 12 | 47 | 2 | DOID:674 (is_implicated_in) | |
| Disease | Connective Tissue Diseases | 1.92e-04 | 13 | 47 | 2 | C0009782 | |
| Disease | osteoarthritis (implicated_via_orthology) | 2.57e-04 | 15 | 47 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 2.94e-04 | 16 | 47 | 2 | C4551479 | |
| Disease | Spondyloepiphyseal Dysplasia | 2.94e-04 | 16 | 47 | 2 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 2.94e-04 | 16 | 47 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 2.94e-04 | 16 | 47 | 2 | C0025237 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 2.94e-04 | 16 | 47 | 2 | C3541456 | |
| Disease | pulse pressure measurement | COL2A1 CKAP5 COL4A1 COL23A1 COL11A1 ADRA2B COL15A1 COL21A1 COL27A1 | 3.03e-04 | 1392 | 47 | 9 | EFO_0005763 |
| Disease | Van Buchem disease | 3.33e-04 | 17 | 47 | 2 | C0432272 | |
| Disease | Dyschondroplasias | 4.17e-04 | 19 | 47 | 2 | C0013366 | |
| Disease | Osteochondrodysplasias | 4.17e-04 | 19 | 47 | 2 | C0029422 | |
| Disease | Degenerative polyarthritis | 4.44e-04 | 93 | 47 | 3 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 4.44e-04 | 93 | 47 | 3 | C0086743 | |
| Disease | hearing impairment | 5.18e-04 | 98 | 47 | 3 | C1384666 | |
| Disease | Sensorineural Hearing Loss (disorder) | 6.15e-04 | 23 | 47 | 2 | C0018784 | |
| Disease | waist-hip ratio | 6.44e-04 | 1226 | 47 | 8 | EFO_0004343 | |
| Disease | social communication impairment | 1.19e-03 | 32 | 47 | 2 | EFO_0005427 | |
| Disease | response to vaccine, cytokine measurement | 1.20e-03 | 131 | 47 | 3 | EFO_0004645, EFO_0004873 | |
| Disease | Global developmental delay | 1.26e-03 | 133 | 47 | 3 | C0557874 | |
| Disease | retinal detachment, retinal break | 1.43e-03 | 35 | 47 | 2 | EFO_0005773, EFO_0010698 | |
| Disease | Focal glomerulosclerosis | 1.51e-03 | 36 | 47 | 2 | C0017668 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKKGSKGEPGPKGFP | 256 | Q14031 | |
| GSEGVQGPPGQQGKK | 306 | Q14031 | |
| GLPGDKGKDGLPGQQ | 631 | Q14031 | |
| KGKDGLPGQQGLPGS | 636 | Q14031 | |
| TPGPAGEKGNKGSKG | 1401 | Q01955 | |
| GEKGNKGSKGEPGPA | 1406 | Q01955 | |
| TEVPGPKGAKGNQGA | 61 | A8MQ03 | |
| KGDKGSSGIPGKEGP | 476 | Q07092 | |
| PTGEKGAQGSPGVKG | 816 | Q07092 | |
| KGNPGVGVKGQMGDP | 231 | P53420 | |
| GPRAKGGPGQGESKQ | 206 | P18089 | |
| NEGPPGQKGEKGDKG | 206 | Q6ZMI3 | |
| QPGEGKPENEKKGDG | 6 | Q9BXU9 | |
| GPKGQKGEPGDIKDI | 101 | P02458 | |
| GPKGANGEPGKAGEK | 606 | P02458 | |
| TKGEKGQKGEPGFQG | 256 | P02462 | |
| KDGDKGEKGSPGFPG | 291 | P02462 | |
| GDQGEKGQIGPIGEK | 951 | P02462 | |
| GDKGAKGEKGQAGPP | 1041 | P02462 | |
| GIKGDQGDQGVPGAK | 1326 | P02462 | |
| KGVNGTPGKHGTPGK | 111 | Q9BXJ5 | |
| QKGSKGDKGENGPPG | 1136 | P12107 | |
| PKGNKGSTGPAGQKG | 1511 | P12107 | |
| APGIDGEKGPKGQKG | 346 | Q86Y22 | |
| QGIQGPKGLDGAKGE | 426 | Q86Y22 | |
| GPTGNKGQKGEKGEP | 461 | Q5KU26 | |
| KGEVGDPGQKGTKGN | 1086 | P13942 | |
| PGNSGPKGQKGEKGS | 326 | P21757 | |
| QGQKGNKGDVGPTGP | 121 | P0C862 | |
| GPKGPTGDPGKNGDK | 496 | P08123 | |
| KKGKPAAPGGAGNTG | 556 | Q14008 | |
| QPGPKGDEGKKGSKG | 546 | Q2UY09 | |
| GSPGQKGHKGEPGEN | 301 | Q14993 | |
| KGQKGEPGEPFTKGE | 476 | Q14993 | |
| PGKQGIKGEKGDPGG | 551 | Q14993 | |
| GIKGEKGNPGVGTQG | 1696 | Q05707 | |
| GGPAEKAKTIKPGGQ | 811 | Q68DX3 | |
| GKGGPVGGKPTLQKQ | 1116 | Q5JV73 | |
| PGIKGEKGDPGSQGS | 1481 | A8TX70 | |
| GEKGEQGEPGKRGKP | 286 | P29400 | |
| QGEPGKRGKPGKDGE | 291 | P29400 | |
| KRGKPGKDGENGQPG | 296 | P29400 | |
| SPGDKGLQGEQGVKG | 461 | P29400 | |
| PGQKGEKGQAGATGP | 511 | P29400 | |
| KGESGEPGPKGQQGV | 456 | Q14055 | |
| QKGAKGNMGEPGEPG | 266 | P12110 | |
| QGQKGNKGDVGPTGP | 121 | B2RNN3 | |
| MGQKGEIGPPGQQGK | 616 | Q96P44 | |
| PGIQGKKGDKGNQGE | 691 | Q96P44 | |
| GKDGDHGKPGIQGQP | 916 | Q96P44 | |
| QKGSKGDKGEQGPPG | 1166 | P20908 | |
| AEGPKGKQGKAGAPG | 1401 | Q8IZC6 | |
| QKGSKGENGSPGLPG | 1346 | Q8NFW1 | |
| KPGEDGKPGLNGKNG | 1831 | Q02388 | |
| KGEPGSNGDQGPKGD | 2116 | Q02388 | |
| DGQKGAPGPKGFKGD | 2356 | Q02388 | |
| GFDGQPGPKGDQGEK | 2686 | Q02388 | |
| PGPQGQKGEKGQCGE | 201 | Q5TAT6 | |
| GAAGEQGPDGPKGSK | 421 | Q5TAT6 | |
| QGPDGPKGSKGEPGK | 426 | Q5TAT6 | |
| GSKGEKGDQGAQGPP | 996 | P39059 | |
| QGKPGIAGKTGSPGQ | 561 | Q6AZY7 | |
| HKGSKGDKGDAGPPG | 1086 | P25940 | |
| GVKGEKGGVGSKGPQ | 1591 | A6NMZ7 | |
| AQGEPGPKGDKGNIG | 171 | A6NHN0 | |
| GPKGDKGNIGLGGVK | 176 | A6NHN0 | |
| NKGLPGIKGDKGEQG | 706 | Q17RW2 | |
| KTGNPGERGFQGKPG | 961 | Q17RW2 | |
| GKKGDKGQIGPTGEV | 1116 | Q17RW2 | |
| GSEGNKGKKGAPGPS | 1261 | Q17RW2 | |
| KNDGEEKKGPGGGAP | 486 | Q8N5D0 | |
| AGGGPQGKKGKNEPK | 1991 | Q96T58 | |
| GKKGPAEKGKGGNGG | 46 | Q8N3U4 | |
| AEKGKGGNGGGKPPS | 51 | Q8N3U4 | |
| KSEGEGKPQGEGKPA | 71 | Q6IPX3 | |
| AQEGGKGGSEKPKRP | 396 | P17480 | |
| KGKEKEGRQGPGKQP | 391 | Q86VY4 | |
| KKGSSGKPGVGPDGD | 236 | Q9Y493 |